Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,20043,98,2.42 [0.78-7.54],0.1273565391114426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,19498,94,0.62 [0.42-0.92],0.0171100684095898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,22835,117,1.09 [0.81-1.46],0.5683016588714009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,19384,97,1.28 [0.79-2.08],0.3195651201450673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,22698,117,0.93 [0.70-1.24],0.6184943870183914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,22835,117,1.00 [0.78-1.28],0.9816894122364862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,20025,100,0.89 [0.77-1.01],0.0801663828027372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,19384,97,0.89 [0.65-1.21],0.4477521317686852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22367,117,1.38 [1.15-1.65],0.0004942596698365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19612,99,0.95 [0.72-1.26],0.7313673881982095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20004,98,0.90 [0.72-1.13],0.3799767234979818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,22727,121,1.34 [0.76-2.37],0.3075510778674704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,20025,100,1.79 [0.85-3.77],0.1282863566602998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,22478,115,2.36 [1.83-3.03],2.5328510943501287e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,19568,96,1.42 [0.80-2.50],0.2310443279740549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,19900,99,1.00 [0.84-1.19],0.9944482288558384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22927,121,1.07 [0.78-1.47],0.6776786545331172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19439,99,0.48 [0.29-0.80],0.0045468856621143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,23012,120,2.55 [1.78-3.67],4.115489292544245e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,23084,121,1.07 [0.83-1.37],0.597097598986899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,19897,101,0.81 [0.47-1.40],0.4497482191418628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,19439,99,1.12 [0.63-1.99],0.6944222126643469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19384,97,0.90 [0.51-1.59],0.7095318709219567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",22478,115,1.59 [1.23-2.06],0.000439226871471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,19384,97,1.23 [0.88-1.72],0.2213027462820613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,22462,118,1.06 [0.62-1.79],0.8382274535838969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,22738,117,4.51 [2.59-7.84],1.0083236449585766e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,22927,121,1.53 [1.21-1.94],0.0003621575307889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19384,97,1.69 [1.25-2.30],0.000669432168837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,19490,96,0.80 [0.59-1.09],0.1610073223861157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,23141,119,1.32 [0.85-2.06],0.222192252488191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,22756,119,1.56 [1.07-2.29],0.021892234746794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19439,99,1.61 [1.24-2.09],0.0004102423363069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22478,115,1.36 [0.79-2.34],0.2671674840404805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22775,117,0.63 [0.39-1.01],0.0549503406625797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23141,119,0.87 [0.55-1.39],0.566169124580058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23087,119,1.49 [0.84-2.66],0.1749837630309283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19900,99,3.02 [1.83-5.00],1.6833812446421184e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19439,99,1.36 [0.79-2.37],0.2705414563473732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23189,120,0.32 [0.16-0.65],0.0013869172067836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22835,117,2.15 [1.43-3.24],0.0002551664785613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22478,115,1.17 [0.74-1.87],0.5058780478871923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19439,99,1.17 [0.67-2.04],0.5784302159393688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22985,119,0.85 [0.59-1.23],0.388351777470882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,20004,99,3.84 [2.31-6.38],1.942914073540933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,19498,94,1.00 [0.43-2.33],0.9908031086153448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,20004,98,0.83 [0.51-1.35],0.4515418773738593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22367,117,0.42 [0.21-0.85],0.0160712942786903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,19568,96,0.82 [0.62-1.10],0.1864700355665381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,22738,117,0.98 [0.60-1.61],0.9386352832607284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,19568,96,2.02 [1.27-3.24],0.0032086722220052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,19900,99,1.19 [0.84-1.69],0.3150913363560096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,23024,120,1.27 [0.72-2.25],0.4028051883437997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,23074,120,1.15 [0.67-1.95],0.6180803152477736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,20004,98,1.07 [0.56-2.03],0.8410335330106185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,22835,117,1.43 [1.13-1.81],0.0026036305750152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,22927,121,1.25 [0.70-2.25],0.4532759880627498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,19348,99,0.96 [0.71-1.29],0.7740336975438245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,19568,96,1.46 [1.16-1.84],0.0012458190864985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22478,115,1.33 [1.10-1.59],0.002620427480798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,20043,98,1.47 [1.09-1.99],0.0114963633773346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,23120,121,6.47 [3.62-11.57],2.8430285033065797e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,19384,97,1.01 [0.78-1.30],0.9374593410342024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,19568,96,0.78 [0.61-0.99],0.0424797943570078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,20043,98,1.37 [0.47-4.02],0.5624726445981807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,22705,117,0.94 [0.74-1.20],0.6385199062540107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,19348,99,0.83 [0.69-1.00],0.054599216887968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,22876,119,0.68 [0.45-1.02],0.0613188936403937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,22182,109,1.33 [1.13-1.55],0.0004952410227345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,22327,117,1.31 [0.99-1.72],0.056596209031839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,23024,120,2.32 [1.54-3.51],6.587891656212175e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,23141,119,0.91 [0.67-1.23],0.5244367257354949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,20025,100,1.37 [0.68-2.73],0.3777866694353846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,22927,121,1.44 [1.19-1.73],0.0001214831556554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,22927,121,1.00 [0.79-1.27],0.992812787349437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,19498,94,0.96 [0.50-1.85],0.9073385996304588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,19498,94,2.69 [1.64-4.40],8.058357498661936e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19897,101,0.90 [0.67-1.21],0.4842632645571509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,20025,100,1.85 [0.92-3.71],0.0828449118456383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,22879,118,0.94 [0.78-1.13],0.4988562701662301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",19440,96,1.00 [0.78-1.27],0.9689625254461052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,22367,117,1.11 [0.80-1.54],0.5144531655889197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,19498,94,0.85 [0.58-1.24],0.3986095192374373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22792,117,1.05 [0.90-1.23],0.5068514383341323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,22927,121,0.91 [0.70-1.17],0.4523320709110987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",19967,101,0.93 [0.77-1.12],0.4408399378120103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,19568,96,1.34 [0.57-3.15],0.5094188377732669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,22367,117,1.05 [0.85-1.31],0.6385441869053595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,19440,96,1.13 [0.82-1.54],0.4573395759232637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,22478,115,0.96 [0.70-1.32],0.8008128405262503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19439,99,1.28 [1.01-1.63],0.0407369381657238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,22375,115,1.05 [0.82-1.36],0.6873194221324526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,19980,101,0.91 [0.78-1.06],0.2070384247743221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,22259,117,0.81 [0.60-1.09],0.1650423226322348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,23189,120,2.35 [1.05-5.26],0.0366108232332343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,22912,118,1.32 [1.00-1.74],0.0495016031688985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19897,101,1.18 [0.85-1.63],0.3349559141097514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22834,121,1.57 [1.35-1.84],1.2128832881414355e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19980,101,1.47 [1.02-2.11],0.0408733776756567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,19612,99,0.86 [0.55-1.35],0.5126096458168168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,19439,99,1.10 [0.93-1.29],0.2680129688572417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",22835,117,1.34 [1.19-1.51],1.0063871269780652e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,22462,118,0.67 [0.34-1.30],0.2342428821312231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,23086,120,3.57 [1.60-7.98],0.001926592544383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20004,99,1.09 [0.50-2.40],0.8278054856508638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,22375,115,1.16 [0.92-1.46],0.2053352822223602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,19440,96,0.94 [0.63-1.40],0.7469170108847314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,22835,117,1.19 [0.59-2.41],0.627371056427233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,22462,118,0.95 [0.67-1.35],0.789229278924782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,19568,96,1.16 [0.74-1.82],0.5160081760662327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,19835,101,0.70 [0.43-1.16],0.1656419769915882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,19967,101,0.93 [0.71-1.21],0.5915303901599231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18738,97,1.00 [0.67-1.49],0.9879196916514792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,21974,114,0.92 [0.65-1.31],0.6539393905409325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,21318,106,0.88 [0.61-1.27],0.4949681200230701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,22832,119,1.69 [1.11-2.58],0.0149341926112913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,22839,120,0.92 [0.76-1.12],0.4010531782438701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,23120,121,2.00 [1.37-2.91],0.0003305665233222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,22616,119,1.88 [1.09-3.25],0.0225172200458562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,22959,120,1.55 [1.03-2.33],0.0351614320056556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,22904,119,1.50 [0.97-2.33],0.0671367039600158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,22984,120,1.53 [1.08-2.18],0.0175131957452625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,23120,121,1.97 [1.37-2.85],0.0002799292011144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,19384,97,1.09 [0.85-1.40],0.4762988056308365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19439,99,0.79 [0.61-1.02],0.0727752323268867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,19298,99,0.81 [0.55-1.19],0.2796587708302196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,22367,117,1.21 [0.94-1.56],0.1440409930503493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19498,94,0.71 [0.39-1.30],0.2673873853962027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,22938,119,2.50 [1.53-4.11],0.0002814652358771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,19445,95,1.27 [0.88-1.82],0.2041239911045896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,22375,115,1.44 [1.21-1.72],3.595306149057607e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,22840,121,1.11 [0.86-1.42],0.4387365036857368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,19192,94,1.30 [1.05-1.61],0.0148511736410255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,23087,119,1.08 [0.85-1.37],0.5218236930191275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,22808,120,0.92 [0.73-1.16],0.4897364207014089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,22306,114,1.53 [0.89-2.63],0.1240826650729209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22462,118,1.08 [0.82-1.42],0.5619568339218897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,22980,119,1.55 [0.91-2.67],0.1088045104113613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,19897,101,0.92 [0.72-1.18],0.5233520250679264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,19440,96,1.26 [0.87-1.82],0.2195101257068775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,19900,99,0.94 [0.72-1.22],0.6219488947097254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,19967,101,0.91 [0.60-1.38],0.6557025096783999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22835,117,1.50 [1.11-2.02],0.0080213866298829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,19856,97,1.44 [0.83-2.50],0.1898518742348822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23042,121,1.36 [1.05-1.75],0.0205304727984167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,22927,121,0.90 [0.66-1.23],0.5066816031827158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,20043,98,0.77 [0.37-1.61],0.4822150026615831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,20025,100,1.74 [1.19-2.53],0.0040281377264323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,20043,98,1.11 [0.66-1.88],0.689146641854752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,20025,100,1.02 [0.43-2.42],0.9594597570571212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,19498,94,1.47 [0.90-2.42],0.1269242447793848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,19996,98,0.72 [0.42-1.24],0.2367296656966317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,19095,94,0.91 [0.54-1.54],0.7328841036391911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,20043,98,0.84 [0.60-1.16],0.2866505546204726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,20025,100,0.62 [0.37-1.06],0.0788098128281871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,22912,118,1.22 [0.76-1.94],0.4077729519876246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,20025,100,0.93 [0.68-1.26],0.623435330701928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,22942,119,1.41 [0.77-2.59],0.2677563475490029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,22882,118,0.95 [0.75-1.22],0.7097628966132719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,19568,96,0.92 [0.77-1.11],0.3925852147224972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,22742,117,1.02 [0.72-1.44],0.9132493070697684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,19612,99,0.95 [0.70-1.29],0.7597398292069115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,22835,117,1.85 [1.42-2.41],5.335853959102784e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,19900,99,0.88 [0.74-1.06],0.1733725387401432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,19980,101,0.98 [0.74-1.30],0.8918506254412863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,22799,117,1.01 [0.74-1.37],0.9548561106595312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",19897,101,1.10 [0.73-1.67],0.6402001461016922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,22367,117,1.07 [0.75-1.52],0.7234350245135308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,22367,117,1.03 [0.78-1.35],0.8395740861487407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,19612,99,1.17 [0.71-1.91],0.5387646939692199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,19568,96,0.87 [0.68-1.12],0.2710806894962718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,19298,99,1.02 [0.79-1.31],0.8853707215350552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,19967,101,0.98 [0.79-1.22],0.874959518848789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,19980,101,0.97 [0.79-1.20],0.8088974657520029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,22868,121,0.95 [0.81-1.12],0.5623587853655363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,19348,99,1.21 [0.96-1.54],0.1100066145746471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,19348,99,0.73 [0.43-1.25],0.2559691303167636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,22375,115,1.07 [0.72-1.58],0.7290229097483121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,19384,97,1.10 [0.84-1.45],0.4798341800193185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19384,97,0.97 [0.59-1.60],0.9200156225332234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,19348,99,0.83 [0.58-1.18],0.2932935461379065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,22462,118,1.09 [0.68-1.75],0.7102996784952955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19384,97,0.93 [0.66-1.31],0.6717820084368826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,22912,118,1.40 [1.00-1.96],0.0484631591704592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,22835,117,1.10 [0.82-1.49],0.5237815000424145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,22980,119,0.74 [0.45-1.21],0.2310420666271068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,19348,99,0.89 [0.62-1.28],0.5425748705499083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,22462,118,1.15 [0.85-1.56],0.3602042289286669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,19810,99,1.44 [1.03-2.02],0.034283763886276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,22775,117,0.92 [0.68-1.24],0.5867566838502838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,22775,117,3.40 [2.10-5.52],7.330924316869511e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,20025,100,3.35 [1.76-6.38],0.000236476649541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,20004,98,1.41 [0.77-2.59],0.2667388854130261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,19980,101,0.92 [0.69-1.23],0.5921277403932756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19498,94,0.92 [0.76-1.13],0.4378874646692884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,19384,97,1.34 [1.06-1.68],0.012626241992077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22375,115,0.94 [0.73-1.21],0.6368954965119744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,19298,99,0.90 [0.53-1.54],0.7005344725928513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,19900,99,0.99 [0.78-1.25],0.9132847114184526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,22367,117,0.96 [0.72-1.27],0.7630836371959986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,22985,119,1.03 [0.82-1.30],0.7765994019685417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19384,97,1.08 [0.73-1.61],0.6911907010246339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19384,97,1.31 [0.74-2.32],0.353895617156853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19384,97,0.96 [0.56-1.63],0.8735222036069399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,19298,99,1.24 [0.82-1.87],0.3053221614801303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19384,97,0.83 [0.57-1.21],0.3368408833013913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19384,97,1.15 [0.90-1.48],0.2729765653348923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",23024,120,0.96 [0.83-1.11],0.5996032039902435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",22375,115,0.96 [0.64-1.44],0.8506393152955803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,22367,117,0.91 [0.62-1.34],0.6366762786239748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,22835,117,0.93 [0.49-1.79],0.837263306256695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,22328,115,0.98 [0.76-1.27],0.8833709740274599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,19498,94,0.91 [0.69-1.22],0.5435864944179636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,19384,97,0.91 [0.73-1.14],0.4144842500937652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,19900,99,1.65 [1.18-2.30],0.0030320626332935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",20043,98,1.18 [0.35-3.96],0.7853743064673308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,22375,115,0.87 [0.69-1.10],0.254576740752281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,19348,99,0.81 [0.65-1.01],0.0568126073988423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,19980,101,0.72 [0.46-1.13],0.1536771879861474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,19967,101,0.99 [0.72-1.35],0.9262196732470772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,22868,121,0.95 [0.79-1.13],0.5595217227155254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,22980,119,1.10 [0.61-2.00],0.7454455262560872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,19980,101,0.87 [0.61-1.24],0.4315504434842598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,22171,117,1.15 [0.95-1.38],0.1494513664005834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,20043,98,1.74 [1.26-2.40],0.0008544464438194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19384,97,1.95 [0.83-4.57],0.1237747913406569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19498,94,2.99 [1.71-5.22],0.0001235013694449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",23024,120,2.74 [1.56-4.81],0.0004321633730413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22912,118,0.88 [0.45-1.73],0.7114720482651786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,19439,99,0.53 [0.24-1.18],0.122497850363457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,22868,121,1.03 [0.82-1.29],0.8099178100875228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,22738,117,1.26 [0.81-1.96],0.301881194763147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,19439,99,0.73 [0.47-1.13],0.1549728639906394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,22478,115,1.21 [0.77-1.90],0.4147581875556219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22367,117,1.59 [1.26-2.01],9.968442840895109e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,22367,117,2.00 [1.26-3.19],0.0034879297908279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,22868,121,0.94 [0.80-1.10],0.421254504777138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,19967,101,1.30 [1.04-1.63],0.0228725351537124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,19440,96,1.10 [0.90-1.34],0.3406159882766918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,22339,114,1.09 [0.90-1.32],0.3603716820410739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,22912,118,1.40 [0.72-2.72],0.3229931634776181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,22775,117,0.51 [0.31-0.83],0.0064787887475484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20004,98,1.29 [0.69-2.43],0.4213198596152583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19348,99,0.92 [0.65-1.32],0.6638385560619515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,19652,97,1.23 [0.60-2.53],0.5738855441883581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,19900,99,1.11 [0.79-1.58],0.5384038792984259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,19967,101,0.94 [0.77-1.14],0.5047215528346727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22868,121,1.96 [1.29-2.98],0.0015598462097485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,19439,99,1.27 [0.96-1.66],0.0899957824714507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,19298,99,1.03 [0.77-1.39],0.8315789780586459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19897,101,1.05 [0.67-1.62],0.840892385977323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,22868,121,0.96 [0.80-1.15],0.6682639349399504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,20004,99,0.86 [0.68-1.08],0.1896585093794133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,19498,94,0.85 [0.61-1.20],0.3639999568825393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,19298,99,0.96 [0.61-1.50],0.8467227254133495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,20004,99,1.08 [0.87-1.34],0.4728173148600828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,22325,116,1.04 [0.90-1.19],0.5919740701460251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,19348,99,0.84 [0.62-1.13],0.2437465968324554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19384,97,1.02 [0.46-2.22],0.968415269649556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,22868,121,0.97 [0.76-1.25],0.8373406499891058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,22912,118,0.94 [0.78-1.13],0.5149749417213008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,22367,117,0.95 [0.72-1.24],0.6945641737721651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,23189,120,1.17 [0.71-1.92],0.5334312521031538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,19439,99,1.04 [0.62-1.75],0.878230820445048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19348,99,0.95 [0.71-1.26],0.7222252086957863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19967,101,0.74 [0.44-1.25],0.2620839564445643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,22912,118,1.05 [0.82-1.34],0.7127851405049751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,19568,96,1.17 [0.58-2.36],0.6682726906153809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,22738,117,1.11 [0.78-1.56],0.5609867667534256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,22440,115,1.26 [0.84-1.90],0.2574660506120688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,19568,96,2.50 [1.23-5.08],0.0111406809501788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20004,98,1.02 [0.58-1.82],0.938944854623924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19439,99,1.56 [1.06-2.28],0.0223662624179419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,22478,115,2.26 [1.13-4.53],0.0208663994806716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,19348,99,1.11 [0.79-1.56],0.5298017386299348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,19498,94,0.86 [0.59-1.24],0.4107882450033181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,18783,93,1.00 [0.83-1.21],0.9807003271981372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,22846,119,1.54 [1.18-2.03],0.0017460005577655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,19962,98,1.21 [0.92-1.58],0.172178189406095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,19724,99,0.93 [0.78-1.12],0.44894587256799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,19612,99,1.09 [0.59-2.04],0.7793895800039715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,19348,99,0.75 [0.38-1.48],0.4050037089861908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,19384,97,0.70 [0.42-1.17],0.1753533566470791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,19384,97,1.16 [0.68-2.00],0.5861775187351553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,22375,115,1.25 [0.86-1.83],0.2359622550452118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,19348,99,0.63 [0.35-1.12],0.1154203703728523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,19980,101,0.87 [0.52-1.45],0.5915759806824201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,23103,119,7.97 [4.03-15.77],2.4725095601611582e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,19298,99,1.27 [0.76-2.12],0.3605181318831471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23124,119,0.91 [0.65-1.28],0.6029081898391411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,23124,119,1.85 [1.51-2.26],2.0800968323580616e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,22367,117,0.98 [0.77-1.23],0.8292102840477509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,20043,98,0.86 [0.34-2.20],0.7601427159987144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,19298,99,0.95 [0.74-1.23],0.7165461837967604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,19859,101,0.96 [0.61-1.53],0.8710187281105906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,23024,120,2.79 [1.58-4.92],0.0003858319947478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,22868,121,1.76 [1.25-2.47],0.0010843525414572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,19298,99,0.89 [0.54-1.49],0.662898021087698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,22375,115,1.14 [0.91-1.43],0.265498547893136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,19384,97,1.20 [0.67-2.16],0.5365124878179532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,23023,117,2.12 [1.05-4.26],0.0353518046582456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19980,101,0.88 [0.63-1.24],0.4698925071586803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,19439,99,0.79 [0.49-1.25],0.3124566953752942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22980,119,1.62 [1.15-2.28],0.0060031162092026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19568,96,0.79 [0.48-1.30],0.357260891384511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19980,101,1.04 [0.59-1.82],0.8926224350390731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19526,95,0.92 [0.61-1.38],0.6938215544422628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,20043,98,0.63 [0.20-2.00],0.4340635476384128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,20013,98,0.65 [0.24-1.75],0.3977173334936341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,20043,98,1.32 [0.51-3.40],0.5651156868975236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,22942,119,2.35 [1.11-4.99],0.02629888942793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,22328,115,1.30 [0.95-1.77],0.0998657137831459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,19440,96,1.00 [0.72-1.40],0.9773301722947692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,19010,91,1.01 [0.65-1.57],0.9518795291814814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,22985,119,1.28 [0.87-1.88],0.210992923120781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,20043,98,1.66 [0.51-5.37],0.3992145892752942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,19555,95,4.38 [2.37-8.07],2.2737681892524085e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,19967,101,1.47 [0.80-2.69],0.2134504239067356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,20043,98,0.63 [0.34-1.19],0.1549258612813347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,20025,100,1.06 [0.71-1.57],0.7820514574388764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,19900,99,1.14 [0.90-1.43],0.2742716359735097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,22365,117,1.14 [0.87-1.48],0.3428747786063832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,22367,117,1.02 [0.63-1.66],0.920161587203876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,22835,117,1.69 [1.07-2.68],0.0252235112832812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,22682,118,0.94 [0.80-1.10],0.4465358808097049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,23120,121,0.49 [0.31-0.77],0.0022242104490039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,22838,118,1.11 [0.88-1.39],0.3809416151301263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,23148,120,1.07 [0.82-1.38],0.6319673022419638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,23189,120,2.30 [1.20-4.38],0.0118679181139191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",22478,115,1.34 [1.14-1.56],0.0003367842313037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,22841,118,0.85 [0.66-1.10],0.2237971041713564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,19612,99,0.96 [0.55-1.68],0.8953884721719133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,19439,99,1.08 [0.54-2.16],0.8299689551011212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,23120,121,1.80 [1.32-2.45],0.0002291183066909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,19440,96,0.97 [0.71-1.33],0.8703960778722746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19348,99,0.70 [0.35-1.40],0.3141635062097282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19384,97,0.93 [0.64-1.36],0.7240900126226947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19348,99,0.96 [0.70-1.32],0.8005149906868054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19980,101,0.97 [0.77-1.22],0.7957435446966508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,19530,96,0.91 [0.75-1.11],0.3425398996827151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,19440,96,1.32 [0.97-1.81],0.0810900634913585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,22835,117,1.30 [0.86-1.95],0.2095800432735812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,22375,115,1.44 [0.96-2.16],0.0746684190490066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,22728,117,1.63 [1.32-2.03],8.488977877723277e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,19967,101,1.36 [0.92-2.02],0.1258801881005167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23047,120,0.98 [0.83-1.15],0.792606678060237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19498,94,0.90 [0.69-1.18],0.4462320578670724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,19384,97,1.36 [0.84-2.20],0.2169204681416883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22367,117,0.97 [0.66-1.41],0.8591743317307623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19440,96,1.06 [0.75-1.49],0.7385794246491268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19980,101,0.97 [0.81-1.16],0.7015252965685597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,22870,121,2.12 [0.97-4.68],0.0611481374617943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,22733,117,1.64 [1.28-2.11],0.00010571807085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,19897,101,1.29 [0.79-2.09],0.313973712674068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,19967,101,1.07 [0.89-1.28],0.474892862407211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,22375,115,1.03 [0.75-1.42],0.8562405538256999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,19440,96,0.89 [0.54-1.48],0.6618995492708644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,22375,115,1.19 [0.95-1.50],0.1258387598889158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,22375,115,1.02 [0.80-1.30],0.8752662004507286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,22868,121,0.92 [0.72-1.19],0.5374079434923009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,23189,120,0.99 [0.82-1.20],0.9174077789442884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,19612,99,0.93 [0.81-1.06],0.26552061068298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,19967,101,0.88 [0.69-1.11],0.2770685217509692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,23050,120,1.02 [0.78-1.33],0.8923212107233178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,19439,99,0.86 [0.62-1.20],0.3787431185320984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,19384,97,0.76 [0.47-1.22],0.2507271869370943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,19723,99,1.13 [0.80-1.59],0.494853999401932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,22890,121,1.26 [1.00-1.58],0.0476488965093444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,19348,99,1.11 [0.94-1.30],0.2215963952281964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,23120,121,0.27 [0.17-0.43],4.5813508271043394e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,19498,94,1.75 [1.28-2.38],0.0004207050771413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,19384,97,1.37 [0.94-2.00],0.0976297933429978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22775,117,0.98 [0.78-1.23],0.8422886784661725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,19967,101,1.13 [0.82-1.57],0.4586337402259021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,19897,101,0.91 [0.60-1.37],0.6440029201158788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,19440,96,0.95 [0.47-1.92],0.89128009191025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,19980,101,0.98 [0.76-1.28],0.8968245698370335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,22927,121,1.95 [1.27-2.99],0.0021725523266968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19498,94,1.32 [0.97-1.78],0.0755127566893745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,23141,119,1.56 [1.02-2.37],0.0389555828612196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,23096,119,1.06 [0.84-1.34],0.6305492235777845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,22832,119,1.53 [1.07-2.19],0.019134125677762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,23189,120,1.85 [1.35-2.54],0.0001303259846807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,23189,120,2.18 [1.59-3.00],1.5273184840224206e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,22886,120,1.06 [0.89-1.27],0.4799706206311792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,22562,118,1.13 [0.92-1.39],0.2513149470897834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,23124,119,1.05 [0.93-1.18],0.422070660558142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,22738,117,1.30 [0.96-1.76],0.0903109494030853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,23141,119,1.27 [1.08-1.49],0.0032669920676962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,23024,120,1.67 [1.31-2.15],4.8504181057270734e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,22706,119,1.37 [1.03-1.83],0.0299258180196257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,23024,120,1.41 [0.96-2.06],0.0790146232450226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,22984,120,1.06 [0.87-1.28],0.5760812608987115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,23141,119,1.36 [0.99-1.87],0.0559745607016945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,22868,121,1.17 [0.99-1.37],0.0680004762834679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,22927,121,1.27 [0.97-1.68],0.0849544379697547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,22801,121,1.41 [1.11-1.79],0.0045291479845253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,22868,121,1.28 [1.06-1.54],0.0089290780199352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,22952,120,1.18 [0.95-1.47],0.1314423285864762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,22980,119,0.96 [0.82-1.12],0.5931985527796287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,22868,121,1.23 [0.97-1.57],0.0868962273902302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,23086,120,1.11 [0.84-1.45],0.4689160542355105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,22792,116,1.13 [0.91-1.39],0.2627961764293061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,22912,120,1.01 [0.76-1.34],0.9279760633837242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,23154,119,1.99 [1.34-2.95],0.0006622636578513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,23120,121,1.38 [0.95-2.00],0.0911248923170182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,22912,118,0.95 [0.62-1.44],0.7976167888454977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,19612,99,1.32 [0.76-2.28],0.3227907765561855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,19439,99,1.09 [0.89-1.34],0.4093187274847828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,22775,117,0.93 [0.65-1.31],0.6618451367189402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,22367,117,0.84 [0.57-1.24],0.3904740387196885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,19900,99,1.55 [1.01-2.39],0.0441665992627613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,22912,118,0.91 [0.56-1.49],0.7175978284152352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,22404,119,2.68 [1.93-3.71],2.8175902337665566e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,23141,119,1.32 [0.94-1.85],0.1059815543402705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22980,119,1.76 [1.22-2.53],0.0024991089114933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,22912,118,1.00 [0.55-1.83],0.9876488872583614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,19440,96,0.93 [0.54-1.59],0.7841034697760821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,22875,118,1.10 [0.96-1.27],0.1611936368603734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,22985,119,1.12 [0.57-2.21],0.737430763142652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,19384,97,1.26 [0.86-1.84],0.2404057410779145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,22868,121,1.46 [0.79-2.72],0.2290855805993502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,22797,121,1.30 [0.82-2.05],0.2701188003361581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,22471,117,2.04 [1.35-3.08],0.0007141859418073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,22963,118,0.83 [0.55-1.27],0.3996722979292302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,23141,119,0.88 [0.60-1.31],0.5445558010053637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,19439,99,0.50 [0.31-0.81],0.0050279435548883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,23141,119,0.82 [0.45-1.51],0.5316067828808304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,20004,99,0.77 [0.47-1.25],0.2849468653377642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,22985,119,1.81 [1.24-2.64],0.0022560750674787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,22775,117,1.80 [1.20-2.70],0.0047234008831973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,22916,119,2.10 [1.32-3.34],0.0016469856965397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,22367,117,1.05 [0.66-1.67],0.8256686275104059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,22927,121,0.91 [0.71-1.18],0.4825812242967239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,19568,96,2.33 [1.24-4.40],0.0089193638300144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,23124,119,2.29 [1.48-3.53],0.0001829123804295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,23040,121,2.33 [1.64-3.32],2.807603321671175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,23120,121,1.25 [0.94-1.66],0.1284463570236761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,22912,118,1.66 [1.09-2.53],0.0184595144902406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,22835,117,3.94 [2.60-5.99],1.3065201308313982e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,22985,119,1.04 [0.85-1.27],0.7132885520685833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,23041,119,0.76 [0.39-1.49],0.4281269628674576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,19439,99,1.12 [0.74-1.70],0.5997832331207407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22835,117,0.80 [0.46-1.38],0.4200084866367637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,19348,99,0.88 [0.49-1.57],0.6623971617022979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19612,99,0.85 [0.47-1.54],0.6014350013598373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,19439,99,1.06 [0.88-1.27],0.5636708938149897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,22835,121,1.65 [1.18-2.29],0.0032471952915448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,22912,120,1.31 [0.96-1.78],0.0838610947571913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,23141,119,0.94 [0.76-1.16],0.5600876141931911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,22749,118,1.44 [0.83-2.49],0.1938701694082316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,22984,120,2.78 [1.60-4.81],0.0002662948942027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,23086,120,1.17 [0.72-1.90],0.5263918454854616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,22093,114,1.66 [0.99-2.79],0.0533740856238913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,22880,119,1.78 [0.71-4.45],0.2167419410250635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,22061,116,2.75 [1.60-4.73],0.0002555025993885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,19917,97,0.91 [0.59-1.39],0.6587043912344956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,23103,119,0.81 [0.60-1.10],0.1821887743380353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,22738,117,0.79 [0.57-1.09],0.1552590179156125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,22818,121,0.98 [0.81-1.18],0.8080919486263353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,19396,99,1.52 [0.99-2.33],0.0548454707039887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,22868,121,1.65 [1.12-2.43],0.0111389118408877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,19568,96,1.01 [0.63-1.62],0.968907215234892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,23124,119,2.08 [1.35-3.19],0.0008164896540334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,23141,119,1.37 [0.96-1.97],0.0829729450698935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,20004,98,3.17 [1.98-5.07],1.4651871096883903e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,19612,99,1.20 [0.78-1.85],0.4023408864178356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,22868,121,3.04 [2.03-4.56],6.610968831465853e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,22868,121,0.96 [0.56-1.62],0.8643137710885195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,19900,99,1.64 [0.85-3.19],0.1415535176354947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,23124,119,0.94 [0.67-1.32],0.7395155877375068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,22025,114,1.93 [1.18-3.15],0.0091382353653652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,22912,118,1.04 [0.44-2.43],0.9295725456526756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,22912,118,1.99 [1.04-3.84],0.0390230098333896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,19963,98,1.07 [0.71-1.61],0.7475971236216772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,19967,101,0.55 [0.21-1.44],0.2262260947618904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,19298,99,1.11 [0.85-1.44],0.4371760432873525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,19298,99,0.68 [0.40-1.18],0.1699018053160184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,19864,99,0.89 [0.67-1.19],0.4371663556906284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,22367,117,1.02 [0.77-1.35],0.8773684982946484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,22985,119,0.93 [0.77-1.14],0.4955540913231064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19900,99,0.94 [0.77-1.14],0.5161618897147531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,22775,117,1.83 [1.37-2.45],4.526297486686202e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,22139,117,1.17 [0.81-1.69],0.3977243345942147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,23077,119,0.89 [0.61-1.30],0.5473347047994648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,22927,121,1.18 [0.93-1.49],0.164391454826717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,22927,121,2.52 [1.60-3.97],6.131359228791462e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,19612,99,1.37 [0.77-2.46],0.2873697587103532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,19967,101,0.77 [0.35-1.70],0.518513648094876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,23124,119,1.40 [0.92-2.14],0.1141842800045998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,19348,99,0.87 [0.56-1.35],0.5243091198942882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,23189,120,0.93 [0.54-1.60],0.7951267839295282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,22927,121,1.40 [0.93-2.12],0.1103300236957842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,22375,115,1.25 [0.88-1.78],0.2099952919448922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,22835,117,1.43 [1.16-1.76],0.000748513388368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,22927,121,0.52 [0.35-0.76],0.0007127948501409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,19298,99,1.44 [0.85-2.42],0.1747562840528245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19980,101,0.78 [0.54-1.11],0.1669390032542248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,19348,99,0.95 [0.64-1.40],0.7861799873578246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,22835,117,0.93 [0.79-1.09],0.3685389605192103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22835,117,0.93 [0.78-1.11],0.4308330219161912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,22835,117,1.16 [0.70-1.94],0.5606334171092844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22958,120,2.44 [1.31-4.54],0.0048860846390811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,23068,119,1.10 [0.75-1.60],0.6268210019016932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22947,117,3.91 [1.92-7.95],0.0001635086926492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19900,99,0.71 [0.57-0.89],0.0026309758126633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19612,99,0.93 [0.69-1.26],0.653712675064994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19900,99,1.77 [1.12-2.79],0.0151127916230861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19612,99,1.59 [1.19-2.14],0.0018923562651867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22868,121,1.19 [1.00-1.43],0.0551451349422082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22367,117,1.34 [0.98-1.84],0.062258022580323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22086,114,1.47 [1.20-1.81],0.0002586957292868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20004,99,1.92 [1.36-2.71],0.0002031927838219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22478,115,1.49 [1.10-2.02],0.0091101209542287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,19439,99,0.92 [0.51-1.66],0.7862547364904526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,22478,115,1.42 [0.96-2.09],0.0771451248421088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,20004,99,0.62 [0.46-0.84],0.0016729521023934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,23144,119,0.60 [0.45-0.80],0.0005140187449255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19568,96,0.95 [0.48-1.88],0.8896236777612194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,19439,99,1.38 [0.92-2.09],0.1212672507981362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,19348,99,1.30 [1.01-1.68],0.0393289986816941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,19612,99,0.90 [0.63-1.29],0.5753593092666704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,19612,99,0.98 [0.75-1.29],0.8994874927212785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,19384,97,0.89 [0.55-1.45],0.6458792912896104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,19298,99,0.58 [0.34-1.00],0.0488181687786509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,22462,118,1.05 [0.83-1.34],0.6732509672436997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,19498,94,0.85 [0.64-1.11],0.2343211408299469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,22367,117,1.18 [0.95-1.48],0.1365207591429561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,19612,99,1.00 [0.68-1.46],0.988022310644016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,19298,99,0.71 [0.41-1.22],0.2156194694586339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,22294,111,1.03 [0.80-1.33],0.8008715157313792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,22367,117,0.94 [0.71-1.24],0.6773848300434875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,22375,115,1.03 [0.79-1.36],0.8083306570892421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,22954,119,1.25 [1.02-1.53],0.0317784741986234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,22835,117,1.23 [0.92-1.64],0.1623475132535057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,22835,117,0.82 [0.64-1.07],0.1449545985491582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,22375,115,1.01 [0.78-1.30],0.9660508627743098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,19900,99,0.97 [0.76-1.25],0.8426065147173623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,19661,94,1.25 [0.69-2.27],0.4639026755625105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,22367,117,1.38 [1.03-1.86],0.0328749726497847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,20043,98,1.59 [0.60-4.21],0.3541771470445185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,18860,91,2.04 [0.86-4.85],0.1079337413209906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,19877,97,0.90 [0.64-1.26],0.5394333148499574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,20009,98,1.04 [0.79-1.35],0.7908378026967698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,19764,98,1.21 [0.75-1.96],0.423446576966571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,20043,98,1.84 [0.70-4.85],0.2171235153391871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,20043,98,0.60 [0.23-1.57],0.2964604292952412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,22912,118,1.17 [0.99-1.40],0.0728358067246641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20025,100,0.98 [0.67-1.44],0.929150842778974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,19440,96,1.24 [0.81-1.92],0.3192324449665931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,22927,121,2.00 [1.40-2.85],0.0001404968025476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22367,117,1.22 [0.95-1.57],0.113141662246048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,19568,96,0.84 [0.58-1.22],0.3716257514354425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19967,101,2.48 [1.72-3.57],1.0500225656924892e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,19897,101,2.03 [1.31-3.14],0.0014024483650888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,22478,115,1.29 [0.78-2.12],0.3190790569371885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,20004,99,1.73 [1.48-2.03],6.462298603642136e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,23029,119,1.12 [0.74-1.69],0.601967687196117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,22375,115,1.64 [1.38-1.96],3.737843666679923e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,22998,120,1.06 [0.93-1.21],0.3563574383590692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,22948,117,1.74 [1.08-2.80],0.0231741719709642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,19440,96,1.02 [0.73-1.42],0.8945245188618105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,22775,117,0.93 [0.75-1.14],0.4742680947040023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,20004,98,0.94 [0.66-1.34],0.7262570577888149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,19348,99,0.98 [0.74-1.29],0.867210408795048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,22984,120,2.38 [1.43-3.96],0.0008030966667595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,22927,121,0.96 [0.73-1.26],0.755251594582575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,19440,96,1.32 [0.85-2.04],0.2105781622635687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,22985,119,0.93 [0.72-1.21],0.590267771848009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,20004,99,1.67 [1.16-2.41],0.0062021822801167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,19612,99,0.89 [0.56-1.42],0.6255337745991071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,19900,99,0.92 [0.75-1.13],0.4432030477326985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,19440,96,1.21 [0.81-1.81],0.3554678175185829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,23032,119,3.07 [1.92-4.90],2.79609530740392e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,20004,99,1.55 [1.12-2.13],0.0073747940716769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22834,119,1.32 [1.03-1.70],0.0299037823169711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,19298,99,0.92 [0.68-1.24],0.5701946160299778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,22897,121,1.15 [0.91-1.45],0.2388982358272025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,22775,117,1.90 [1.20-3.00],0.0058132207179579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,22865,118,1.17 [0.83-1.66],0.3652472297009766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,19439,99,1.11 [0.42-2.98],0.8304972642254782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,22912,118,2.31 [1.41-3.77],0.0008300447214808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,22478,115,2.16 [1.35-3.45],0.0013025009505272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,23124,119,0.91 [0.77-1.09],0.3105738330264727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,19440,96,0.83 [0.52-1.33],0.4389141428992748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,19559,94,0.39 [0.15-0.97],0.0439196782080943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,22868,121,0.84 [0.53-1.33],0.4608614612473859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,22868,121,1.26 [0.89-1.79],0.1860454703034768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,22868,121,1.51 [1.18-1.92],0.0009746212359104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,22868,121,1.02 [0.62-1.66],0.9472791452244532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,19962,99,0.77 [0.52-1.16],0.2096384492244811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,22855,121,2.89 [1.74-4.81],4.416259588368314e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,22367,117,1.89 [1.38-2.60],7.367114164400725e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,23141,119,1.57 [1.11-2.22],0.0106544542487654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,19440,96,1.98 [1.40-2.81],0.0001275610891483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,19440,96,1.38 [0.90-2.09],0.136648625754939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,19298,99,0.89 [0.59-1.34],0.5704540594639406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,22868,121,0.98 [0.84-1.13],0.7511852170867761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,23120,121,4.31 [2.12-8.77],5.506120760579756e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,19440,96,0.92 [0.52-1.65],0.7913022413499339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22728,117,1.05 [0.88-1.25],0.620404646455557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,22879,118,0.77 [0.61-0.97],0.0295249646813305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,22328,115,0.89 [0.53-1.52],0.6783518055020042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,22375,115,0.81 [0.57-1.16],0.2540542203549333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,23141,119,1.31 [0.90-1.92],0.1604378605989187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,19967,101,1.23 [0.67-2.28],0.5013843377811289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,22478,115,1.34 [1.00-1.80],0.0489947496791609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,20043,98,0.61 [0.25-1.47],0.269017438216335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,22892,121,0.95 [0.67-1.36],0.7858618008512739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,20004,98,0.94 [0.75-1.17],0.5854800975642047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,19897,101,0.89 [0.70-1.13],0.3368504267832956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,22980,119,0.70 [0.51-0.97],0.0317451454670426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19348,99,0.71 [0.45-1.10],0.1284123183043475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19460,94,0.90 [0.70-1.17],0.4372216842560124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,22478,115,1.17 [0.93-1.47],0.1721688702578911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,22835,117,0.91 [0.72-1.13],0.3817462510730564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,22927,121,0.97 [0.83-1.13],0.7015158695250989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,19348,99,0.75 [0.41-1.37],0.3484864565191197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,23189,120,0.45 [0.25-0.82],0.0093806351658985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,23120,121,1.03 [0.71-1.49],0.8746082097713278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,22912,118,0.95 [0.60-1.52],0.8444491590895588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,22912,118,0.75 [0.37-1.51],0.4213566199722247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,22972,119,0.40 [0.25-0.64],0.0001004641775219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,22868,121,1.78 [1.25-2.52],0.0012193245480462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,19440,96,0.98 [0.79-1.21],0.8222651377606631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,20004,98,1.35 [0.92-1.99],0.1228766331876896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,20004,99,2.50 [1.31-4.76],0.0054852582535684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,22998,120,4.57 [2.34-8.94],8.980930217851051e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,23189,120,1.06 [0.56-1.99],0.865663367481192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,19900,99,1.24 [0.85-1.79],0.2595044661940282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,19440,96,0.84 [0.63-1.12],0.2432259583320398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,19498,94,0.93 [0.73-1.20],0.589899390192305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,20004,99,2.03 [0.98-4.20],0.0574775724311042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,22927,121,1.89 [1.29-2.77],0.0010345296715749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,19582,99,1.71 [1.14-2.58],0.009646785379612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,19568,96,1.80 [1.13-2.87],0.0136150930677371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,23189,120,2.78 [1.93-4.00],3.5476943459037686e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,22868,121,1.83 [1.35-2.48],8.924195183731515e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,19612,99,0.89 [0.57-1.38],0.5886026391521053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,22916,119,4.21 [2.41-7.35],4.5146696341269933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,19498,94,0.86 [0.61-1.21],0.3785017414155082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,19897,101,0.62 [0.36-1.09],0.0951834458146479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,22647,118,0.78 [0.49-1.26],0.3081551413560729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,22248,113,1.17 [0.96-1.44],0.1239763704925379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',19384,97,0.78 [0.47-1.28],0.3209300469248962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,22375,115,0.94 [0.64-1.37],0.7539397842293839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19498,94,1.61 [1.14-2.28],0.0067458609820362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,22422,117,1.01 [0.84-1.22],0.89172353618274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,19348,99,1.23 [0.75-2.00],0.4077606123387451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22835,117,1.14 [0.90-1.45],0.2650442961238345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,20004,98,1.01 [0.54-1.88],0.9727981478832942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,23189,120,0.96 [0.73-1.26],0.7524133536475387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,23039,119,0.89 [0.69-1.14],0.3587420442161877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,19176,96,1.36 [0.84-2.18],0.2070662576894628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,23189,120,0.87 [0.66-1.15],0.3254023667130471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,19996,98,0.72 [0.30-1.71],0.4535801624734644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,22952,120,0.92 [0.61-1.39],0.6913885411850624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,19298,99,1.02 [0.54-1.92],0.959172322134652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,23015,118,2.54 [1.63-3.94],3.4850672712576006e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19439,99,1.51 [0.79-2.89],0.2095213116927884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,23124,119,1.03 [0.80-1.32],0.8310643547475774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,19962,99,1.00 [0.59-1.70],0.9906154016721912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,19384,97,0.91 [0.55-1.51],0.7270034589280078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,23085,120,1.07 [0.72-1.59],0.756192061441912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,22985,119,1.14 [0.90-1.44],0.2844194999889796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,20004,98,2.57 [1.40-4.71],0.002229872226136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,19944,100,0.99 [0.58-1.71],0.9797457581857204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,22980,119,0.73 [0.52-1.03],0.0764827909897664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22367,117,1.05 [0.86-1.27],0.6400688301354562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,22728,117,0.93 [0.75-1.16],0.5357721659575367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,19298,99,0.99 [0.71-1.37],0.9444600717624884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,19298,99,1.17 [0.59-2.35],0.6498221961182263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,22598,117,1.70 [1.14-2.53],0.0085840864482713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,19568,96,2.31 [1.39-3.86],0.0013340619701981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,22984,120,1.06 [0.77-1.46],0.7256932580873628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,22328,116,0.88 [0.72-1.07],0.2019733089963851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,22916,119,2.16 [1.21-3.85],0.0088038599972764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,22478,115,0.96 [0.73-1.27],0.7958995743731613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,23024,120,3.78 [2.00-7.15],4.1407145334782266e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,22775,117,1.49 [0.99-2.26],0.0566737766618578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,23120,121,0.74 [0.58-0.95],0.017056021050449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,19847,100,0.67 [0.34-1.35],0.2651280613592764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,22948,120,0.97 [0.83-1.13],0.6969545419854131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,23024,120,1.04 [0.56-1.90],0.9087981107113576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,22233,117,1.05 [0.82-1.35],0.6992723259448588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,23189,120,0.60 [0.35-1.01],0.0539940072377723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,22775,117,0.89 [0.64-1.24],0.4905829682217457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,19440,96,0.79 [0.48-1.29],0.3433374358945879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,22478,115,0.87 [0.72-1.05],0.1446447509162863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,20004,98,0.87 [0.65-1.18],0.3804824883409913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,19967,101,0.91 [0.65-1.29],0.6102478398886158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,19967,101,0.82 [0.67-1.01],0.0575629972806524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,19348,99,1.00 [0.78-1.29],0.9718890868421672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,19498,94,0.87 [0.69-1.08],0.198948870409046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,19384,97,0.98 [0.81-1.17],0.7905161416739215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,23024,120,3.63 [2.17-6.07],9.074202843060296e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,20025,100,1.31 [0.81-2.11],0.2720538430211042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,19384,97,1.22 [0.72-2.09],0.4610206237730501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22775,117,1.40 [1.09-1.79],0.0075855114878402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,19439,99,1.03 [0.66-1.61],0.9117564237978448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,22462,118,1.26 [0.91-1.75],0.1656857578174727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,19439,99,1.24 [0.71-2.17],0.442089588250744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,20025,100,1.11 [0.78-1.58],0.5731952110883516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,19439,99,0.83 [0.58-1.17],0.2776769057364726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,19980,101,0.88 [0.57-1.35],0.5474943042287456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,20004,99,1.02 [0.57-1.80],0.9576479686919086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,19348,99,0.70 [0.44-1.10],0.1234834531661288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,19384,97,0.93 [0.75-1.16],0.5207886125986467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,17334,91,1.18 [0.96-1.46],0.1194350665745023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,22946,118,3.15 [1.94-5.10],3.077470758797192e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,22540,116,1.47 [1.09-1.98],0.0120898177782414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,22322,115,0.74 [0.52-1.05],0.0924261462175593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,22952,120,1.02 [0.86-1.20],0.8314880402246841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,22572,118,1.82 [1.28-2.58],0.0009404278781994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,19569,99,0.78 [0.52-1.17],0.226502729724078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,19743,100,4.19 [2.07-8.46],6.592772802253938e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,22478,115,0.96 [0.78-1.18],0.7247780593406293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,20004,99,2.96 [1.64-5.34],0.0003335679006014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,20004,99,1.20 [0.67-2.14],0.5331004822530826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,19348,99,0.53 [0.26-1.11],0.0945066643313265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,22912,118,0.68 [0.50-0.93],0.0162411434952036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,22919,120,0.50 [0.39-0.62],2.979253506576024e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,19967,101,0.54 [0.41-0.72],1.330012720415549e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,22922,120,1.24 [0.93-1.64],0.1427439490692039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,22879,120,1.45 [1.01-2.06],0.0427870849694686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,21387,114,2.14 [1.57-2.92],1.3825407451418649e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,19568,96,1.33 [0.91-1.94],0.1360552257920095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,22985,119,1.47 [1.00-2.15],0.0488491170018714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,22407,115,1.12 [0.89-1.40],0.3260717491959082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,22927,121,4.70 [2.57-8.59],4.844706506437296e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,23141,119,1.87 [1.13-3.09],0.0146635310326293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,17978,92,4.17 [1.89-9.19],0.0004039982770482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,23051,119,0.66 [0.45-0.96],0.0311026491307288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,22898,119,2.35 [1.43-3.85],0.0007075651970015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19440,96,0.97 [0.56-1.71],0.9239891714199086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,19787,99,1.13 [0.83-1.53],0.4323601869002683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,22775,117,1.62 [1.02-2.58],0.040933366594125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,22868,121,1.71 [1.32-2.22],4.907614604808626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,22875,120,0.87 [0.72-1.04],0.1268961074089009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,23024,120,1.30 [1.05-1.61],0.0141218080442147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,23124,119,1.14 [0.95-1.37],0.1524457839741747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,22462,118,1.46 [1.00-2.13],0.0508103875731284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,23124,119,1.27 [1.03-1.55],0.0223632743977072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,22462,118,0.83 [0.61-1.13],0.2391893363230843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,23148,120,3.21 [1.65-6.23],0.0005932077999063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,23141,119,1.91 [1.46-2.51],2.74804862158394e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,22912,120,0.84 [0.70-0.99],0.0419621730173335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,22856,121,0.91 [0.79-1.05],0.1931496113987176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,23141,119,0.91 [0.74-1.13],0.4094167674622547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,22727,119,1.40 [1.17-1.68],0.0002849317417464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,23024,120,1.57 [1.29-1.91],7.166770103228398e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,19298,99,1.02 [0.78-1.33],0.8904720522024728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,19658,97,1.32 [0.95-1.83],0.0998857443951591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19384,97,0.87 [0.68-1.13],0.3106869092225857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,19298,99,1.14 [0.89-1.46],0.3015152720667275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,20004,99,1.52 [0.67-3.43],0.3139483878840606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,19568,96,0.90 [0.71-1.15],0.414162919224031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,23120,121,0.96 [0.83-1.11],0.5942776183767446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,23024,120,1.07 [0.76-1.51],0.6964379876101027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,19439,99,0.92 [0.63-1.34],0.6692055236714676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,19439,99,0.97 [0.67-1.39],0.8573483669727614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22868,121,1.00 [0.87-1.14],0.9850227003325016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22728,117,0.93 [0.74-1.16],0.5085229658194557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,19984,100,0.94 [0.79-1.13],0.519593642232373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,22799,118,1.03 [0.83-1.27],0.7909480479757178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,19439,99,0.76 [0.50-1.14],0.1837517808130101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,23024,120,0.98 [0.82-1.17],0.7869758453247648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22985,119,1.53 [0.97-2.43],0.0677393635771228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,19440,96,0.82 [0.31-2.12],0.6751812977414224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,19298,99,0.82 [0.57-1.17],0.2668495123581222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,19298,99,0.46 [0.23-0.92],0.0281269766285093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,22478,115,1.25 [0.61-2.59],0.5432181166697314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,19568,96,0.90 [0.73-1.11],0.3153098981454049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,23120,121,1.01 [0.79-1.29],0.9673544495046034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,22835,117,0.93 [0.77-1.11],0.4169198878042249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,22375,115,0.95 [0.74-1.21],0.6571332254481059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,22927,121,1.60 [0.96-2.65],0.070646541944179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,19348,99,0.87 [0.64-1.18],0.3598903133139408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,19298,99,1.01 [0.79-1.29],0.9573867499710232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,22985,119,1.41 [1.06-1.86],0.0169257246709605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,19384,97,0.97 [0.57-1.64],0.9017213183844136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22835,117,1.62 [1.17-2.23],0.003552574544226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,22890,121,1.37 [1.01-1.85],0.040460548493368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,19980,101,0.84 [0.62-1.13],0.2524327293870675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,19568,96,1.02 [0.79-1.32],0.8653386031883415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,23124,119,1.80 [0.98-3.30],0.0561145741305593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,20004,99,1.34 [0.86-2.09],0.189137358164826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,19900,99,1.01 [0.71-1.45],0.9435537074206816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,19440,96,0.71 [0.38-1.29],0.2594843259563272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,19439,99,0.62 [0.23-1.67],0.3466856478723215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,19439,99,0.64 [0.39-1.04],0.0699644527594908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,19440,96,1.15 [0.67-1.99],0.6046923648526616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,22367,117,1.24 [0.98-1.57],0.0763548871620594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22868,121,1.05 [0.88-1.24],0.6123773243285597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,22420,117,1.41 [1.09-1.83],0.0089237564461568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,19290,99,0.75 [0.42-1.33],0.3246858327138372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,19348,99,0.97 [0.70-1.36],0.8809115271317697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,19348,99,1.01 [0.78-1.30],0.9355097290749328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,19348,99,0.79 [0.52-1.20],0.2670577646112319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,22624,115,1.11 [1.00-1.23],0.0555715996502146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,19384,97,1.12 [0.79-1.60],0.5125650349470693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,19439,99,0.88 [0.62-1.27],0.5042098537626276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,23141,119,1.05 [0.82-1.33],0.7215316791686462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,19348,99,1.16 [0.81-1.65],0.420029418839114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,19439,99,0.88 [0.61-1.28],0.5124577442029921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,22462,118,1.14 [0.71-1.82],0.5944459658130867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,19384,97,0.83 [0.52-1.32],0.4367608975181213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,19897,101,1.20 [0.79-1.82],0.4022773996072039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19967,101,1.37 [0.97-1.95],0.0781270375454485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",22855,121,0.96 [0.83-1.12],0.6313771826398564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,19440,96,0.65 [0.37-1.13],0.1294720599326804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,19568,96,0.61 [0.28-1.33],0.2160304196927059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,23124,119,0.98 [0.75-1.29],0.8867526699529862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,23189,120,1.55 [0.90-2.67],0.1105526145473118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,22738,117,1.47 [1.10-1.96],0.0099062440227079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,22835,117,0.98 [0.81-1.19],0.8195151408629209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,19967,101,0.85 [0.63-1.13],0.2591046308758772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,19980,101,1.15 [0.87-1.52],0.3278436527856908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,23189,120,0.95 [0.70-1.28],0.7268115225185618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,22985,119,2.66 [1.59-4.45],0.0001873464848294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,19498,94,1.09 [0.92-1.30],0.3225479473627279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,19498,94,0.90 [0.60-1.33],0.5934428375813707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,19498,94,1.05 [0.76-1.45],0.7548921429640855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,19298,99,1.27 [0.91-1.77],0.1685362934686599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,23070,119,1.00 [0.82-1.23],0.978236090580837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,19967,101,1.12 [0.86-1.46],0.3864961812012912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,22835,117,0.98 [0.81-1.19],0.866052154634637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,19900,99,0.91 [0.67-1.24],0.5440372927199817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,19568,96,0.80 [0.54-1.17],0.2432850996409813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,19388,96,0.87 [0.68-1.11],0.256135583654868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,22478,115,0.92 [0.67-1.25],0.575643131950605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,19967,101,0.91 [0.54-1.55],0.7266010658090796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19498,94,0.96 [0.75-1.22],0.730764338172134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,19900,99,0.93 [0.72-1.20],0.5639643640894952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,22879,120,1.18 [0.62-2.24],0.6234696430584573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,19348,99,0.95 [0.76-1.19],0.6657442777105596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,19900,99,0.89 [0.76-1.06],0.1970178116053226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,19980,101,1.10 [0.78-1.56],0.57978540450492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,22775,117,1.16 [0.89-1.49],0.2715973624252835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,19967,101,1.07 [0.77-1.48],0.6796902064452901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22988,120,1.04 [0.75-1.43],0.8225495094250707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,19440,96,0.70 [0.36-1.34],0.2824201035076802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,19348,99,1.03 [0.88-1.21],0.676031899439199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,19967,101,0.93 [0.81-1.07],0.3064974344232403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,22927,121,0.97 [0.84-1.11],0.6274552131225541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,22728,117,0.80 [0.58-1.11],0.1863883704460781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,22835,117,1.90 [1.09-3.29],0.0225566873288092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,22868,121,1.65 [1.13-2.43],0.0102607789701047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,22455,115,1.24 [0.71-2.17],0.4502633418476164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,22835,117,0.78 [0.48-1.29],0.3391805141954062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,22736,120,1.33 [1.01-1.75],0.0416958173096252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,23189,120,1.04 [0.57-1.92],0.8904936555267352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,23042,121,1.43 [1.13-1.81],0.0029337098818811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,22775,117,1.36 [0.93-1.97],0.1094940862824108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,22835,117,0.91 [0.67-1.23],0.5359194227627551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,22670,118,1.91 [1.32-2.77],0.000637297635298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,19980,101,0.65 [0.37-1.13],0.1274375355988509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,22912,118,1.08 [0.59-1.97],0.812527013004446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,23041,120,1.34 [0.83-2.16],0.2350851314682664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,22763,114,0.91 [0.66-1.26],0.5648521055165946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,19568,96,0.86 [0.68-1.09],0.215039745377781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,19861,101,1.77 [1.21-2.61],0.0035773006273923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19440,96,0.99 [0.73-1.34],0.9560663625326254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22835,117,3.73 [2.10-6.65],7.826281481873731e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,20004,98,0.90 [0.67-1.20],0.4539761090909053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,22478,115,0.90 [0.70-1.15],0.3968487664628877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,19897,101,0.82 [0.50-1.35],0.4378618490713375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,19440,96,0.79 [0.56-1.13],0.1983622675483467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,22375,115,1.01 [0.83-1.22],0.9307904272479248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19900,99,0.96 [0.80-1.16],0.6862431385355496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,19967,101,0.90 [0.59-1.37],0.6123678490848616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19897,101,1.02 [0.68-1.53],0.9252926799231124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,19440,96,1.06 [0.83-1.34],0.6510184560687582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,19897,101,0.84 [0.53-1.34],0.4720637013553765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22775,117,0.96 [0.80-1.15],0.6507294405110281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,23084,121,1.63 [1.07-2.48],0.0217088171410927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,22375,115,1.08 [0.67-1.71],0.7608430338353793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20004,98,1.33 [1.06-1.66],0.0127066462024323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19498,94,1.22 [1.00-1.50],0.0490956171921709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,19384,97,0.87 [0.62-1.22],0.4173365387556933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,19472,97,0.81 [0.48-1.37],0.4295051138888082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,19348,99,0.88 [0.56-1.37],0.5659123378373847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,23120,121,2.79 [1.97-3.95],8.247894023063099e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22868,121,0.76 [0.64-0.92],0.0037069230396698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,19897,101,1.10 [0.70-1.72],0.6817060493355552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19384,97,1.09 [0.63-1.89],0.7652563068877787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,19980,101,0.91 [0.68-1.21],0.5008920273080489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22478,115,1.83 [1.24-2.70],0.0023154616938183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,19498,94,4.02 [2.24-7.23],3.2184470044102763e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,19439,99,0.91 [0.57-1.45],0.6885965939852812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,20004,98,1.01 [0.82-1.25],0.9119685766317448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19900,99,1.66 [1.02-2.71],0.0410613733465783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,19612,99,0.89 [0.51-1.57],0.6976059225477829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22939,119,2.17 [1.32-3.57],0.0022425030513875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,19980,101,1.86 [1.26-2.75],0.0016918120856489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,22874,118,2.21 [1.27-3.85],0.0048799230698628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,22738,117,3.05 [1.99-4.66],2.8670936354383737e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,19440,96,1.25 [0.96-1.62],0.1044929721475216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,22876,120,0.94 [0.80-1.10],0.4357102986977773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,22367,117,1.37 [0.94-2.00],0.0998178529873679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,19900,99,0.93 [0.49-1.75],0.8218907271281368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,23189,120,0.19 [0.07-0.50],0.0008921331333292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,22868,121,1.39 [1.13-1.72],0.0023362740333379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,20004,98,0.95 [0.73-1.25],0.7334888868932978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,19498,94,0.87 [0.74-1.04],0.1263168850154547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19967,101,0.76 [0.49-1.17],0.2065580900350946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19831,99,1.02 [0.85-1.22],0.8683426381632858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19384,97,1.02 [0.76-1.36],0.9055876970106412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19498,94,0.57 [0.32-1.03],0.0631854453687441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,22775,117,0.84 [0.63-1.12],0.228750799603507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,19439,99,0.85 [0.68-1.07],0.1688777798198585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22927,121,1.17 [0.92-1.50],0.1934257366905176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23141,119,1.02 [0.86-1.20],0.8575792021376782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19980,101,0.90 [0.67-1.21],0.4960909962967522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,19384,97,0.66 [0.40-1.10],0.1139421113200213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,22462,118,0.86 [0.49-1.53],0.6197422394358246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,19980,101,0.86 [0.69-1.08],0.1942602947431009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,19348,99,0.93 [0.73-1.19],0.5662265022377344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,20004,98,1.92 [1.14-3.23],0.0147161519432206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,22835,117,1.34 [1.05-1.70],0.0180918739443535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,19384,97,1.11 [0.68-1.82],0.6759703915221151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,22462,118,1.25 [0.90-1.75],0.1859322200024039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,18463,91,1.16 [0.79-1.70],0.4503680152092286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,23189,120,2.43 [0.93-6.33],0.0691400621071915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,22883,119,1.04 [0.84-1.28],0.7195861026564863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,23124,119,0.84 [0.65-1.08],0.1819406199330705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,19498,94,0.81 [0.55-1.19],0.2800319707275931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,19897,101,0.90 [0.62-1.32],0.5963042952372577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19384,97,1.13 [0.54-2.37],0.739674569910145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,19384,97,1.23 [0.88-1.71],0.230968360293168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23189,120,1.45 [0.85-2.47],0.1759395217336508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23024,120,0.81 [0.55-1.18],0.2693587205117506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19498,94,0.82 [0.48-1.41],0.473413527941444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22198,113,1.42 [1.18-1.72],0.0002578723702224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,19897,101,0.80 [0.54-1.20],0.2802326937829936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22367,117,1.71 [1.21-2.40],0.002202968429604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22478,115,1.60 [0.71-3.61],0.2547629170815768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22478,115,5.05 [2.49-10.24],6.969035595975616e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,19498,94,1.12 [0.80-1.57],0.5068464059818001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,19439,99,0.96 [0.50-1.86],0.9035517627253548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,19440,96,1.11 [0.87-1.42],0.3884584778609588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,22919,119,1.09 [0.93-1.29],0.2955289947869698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,19897,101,1.05 [0.74-1.50],0.7814790679154907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,22988,120,1.75 [1.09-2.81],0.0198662848353061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,22375,115,0.92 [0.69-1.22],0.5438640776280763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,22140,114,2.90 [2.03-4.15],4.9996697367834594e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,19568,96,0.84 [0.42-1.69],0.6297021905359482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,23189,120,3.44 [2.02-5.85],5.197334704840231e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,22728,117,1.37 [0.80-2.35],0.246315862093847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,22478,115,1.07 [0.84-1.36],0.5930069555794224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,19612,99,0.87 [0.54-1.41],0.5741036595376467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,22868,121,1.37 [1.17-1.59],6.883426256892515e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,19498,94,1.39 [1.09-1.76],0.0075247705465383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23078,121,2.66 [1.69-4.20],2.4115616771681164e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,22985,119,2.28 [1.20-4.35],0.0122335726052976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,22850,120,1.35 [0.58-3.13],0.4900834508061715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,22985,119,0.63 [0.34-1.18],0.150087274734306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,22835,117,0.95 [0.80-1.11],0.497090412703927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,19440,96,1.02 [0.78-1.33],0.8830494783272212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,19298,99,1.33 [0.87-2.04],0.1942912524045205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,22728,117,0.94 [0.76-1.17],0.5938831962108697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,19612,99,1.29 [0.75-2.19],0.3554360528728362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,19439,99,1.09 [0.72-1.67],0.6740844694052606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19897,101,1.35 [0.88-2.05],0.1700969490613781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,19568,96,0.90 [0.76-1.06],0.2123698778618666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,22792,116,1.32 [0.70-2.52],0.3923767064206629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19384,97,1.02 [0.69-1.50],0.9380012465718404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,23189,120,1.48 [0.90-2.43],0.1214856216628377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,22916,119,0.95 [0.59-1.51],0.8178294156314287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,19298,99,1.16 [0.87-1.55],0.3063593254770883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,19439,99,1.15 [0.84-1.59],0.3846753835046329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,19967,101,0.92 [0.73-1.18],0.5234256327677136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,19298,99,1.06 [0.64-1.74],0.8216626539394021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,19439,99,0.86 [0.69-1.08],0.1989183798306217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,19612,99,1.52 [0.93-2.50],0.0982508064164766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,19384,97,1.11 [0.83-1.47],0.4914953832346368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,19384,97,0.74 [0.46-1.20],0.2263537800990531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,23124,119,1.79 [0.94-3.44],0.0786492949514736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,20025,100,1.37 [0.62-3.03],0.4364083290942941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,19747,97,0.50 [0.24-1.01],0.054311206122828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,22912,118,0.99 [0.74-1.33],0.9483080268723628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,20043,98,0.70 [0.45-1.10],0.1250674570926951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,19917,97,1.95 [0.89-4.29],0.0948760542090063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,20043,98,1.00 [0.27-3.70],0.9954749451622968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,22984,120,1.04 [0.78-1.38],0.7749219913667773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,22982,120,1.48 [0.83-2.63],0.1832264349948578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,22949,119,1.88 [1.09-3.25],0.0236095744496897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,22942,119,3.92 [1.64-9.37],0.0021660344133321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",22916,119,1.49 [1.28-1.74],3.593740005290623e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",22927,121,1.20 [0.99-1.46],0.0627895509538129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",20004,98,1.54 [1.09-2.16],0.0134242555252596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",23189,120,1.92 [1.43-2.58],1.7040260491210277e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,23049,118,1.27 [1.01-1.60],0.0394209652092848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,22439,115,0.92 [0.68-1.26],0.6012791765204528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,22868,121,1.14 [0.86-1.52],0.3657551102323403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,22927,121,0.96 [0.78-1.19],0.7218744620122749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,19900,99,0.89 [0.66-1.19],0.4193067256988977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,19980,101,1.04 [0.92-1.16],0.5625340294911212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,19897,101,1.17 [0.61-2.23],0.6348961318419122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,19498,94,0.74 [0.53-1.04],0.083592876721424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,20004,98,2.60 [1.45-4.66],0.0013065406224356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,22835,117,1.79 [1.11-2.89],0.0172777847109881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,22890,121,2.42 [1.46-4.01],0.000605129281766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,19900,99,1.32 [1.05-1.67],0.0193556096874447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,23189,120,0.84 [0.46-1.54],0.5776132591167773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,19440,96,0.86 [0.62-1.18],0.3515016042981497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,23117,120,1.96 [1.48-2.61],3.032797334916185e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,23141,119,0.90 [0.58-1.39],0.6303703501311025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,20004,99,1.96 [1.11-3.46],0.0205907789572047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,19440,96,1.00 [0.72-1.39],0.987772257576165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",22927,121,1.50 [1.24-1.82],3.629120814879494e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20004,98,1.21 [0.94-1.57],0.1454026290130675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,22868,121,1.86 [1.32-2.61],0.0003642820753688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19980,101,1.50 [0.68-3.33],0.3153648714483538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22912,118,0.99 [0.70-1.39],0.949007302290008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22797,119,0.99 [0.75-1.30],0.9316305539742128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22367,117,1.04 [0.79-1.38],0.76967430087565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22916,119,1.04 [0.75-1.44],0.8353097294926558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,19984,100,1.54 [1.05-2.25],0.0254632404491458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,22791,119,0.92 [0.62-1.38],0.7004080090715896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,22927,121,0.77 [0.53-1.12],0.1703237831168397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,23032,118,0.89 [0.63-1.26],0.515140256474486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,22462,118,0.84 [0.62-1.14],0.263293264865359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,22912,118,0.90 [0.67-1.22],0.4978451138550839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,22868,121,1.06 [0.83-1.35],0.6324123105302617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,22367,117,1.39 [1.11-1.75],0.0043514546295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",19384,97,1.13 [0.85-1.49],0.3999279083335424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",19384,97,1.21 [0.89-1.65],0.2301401349780468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,22367,117,1.24 [1.01-1.52],0.0397043943508899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,22367,117,1.08 [0.77-1.51],0.6523580470153546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,22942,119,1.42 [0.85-2.37],0.1760487356749124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,19558,92,1.26 [0.66-2.43],0.4809389788783167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19980,101,0.86 [0.67-1.10],0.2311948801453448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,19439,99,0.73 [0.40-1.33],0.3092903399635974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,19439,99,0.98 [0.65-1.48],0.9120857165540088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,23024,120,1.13 [0.91-1.41],0.2514760391991509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,22868,121,0.99 [0.77-1.26],0.9181086738230558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,19439,99,0.90 [0.56-1.45],0.661748519628341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,23084,121,1.34 [1.18-1.51],2.724497151481402e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,23088,121,1.46 [1.23-1.73],1.2257674457848012e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,19439,99,0.81 [0.40-1.63],0.5491886992720943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,22462,118,1.60 [0.96-2.64],0.0694954786847699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,19439,99,1.43 [1.08-1.90],0.012279908261586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,19298,99,0.92 [0.71-1.20],0.5491690213767889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,19260,99,1.02 [0.63-1.66],0.929797136039012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,22985,119,0.70 [0.42-1.16],0.1649700444235156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,20004,99,0.81 [0.55-1.21],0.3057000537176557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,19967,101,1.39 [0.84-2.32],0.2028587755832011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,22985,119,4.92 [2.57-9.42],1.5738506278166723e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,19568,96,0.67 [0.46-0.98],0.0391797685483797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,20025,100,2.28 [1.72-3.04],1.4840216264197792e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,22375,115,1.33 [1.07-1.66],0.0117025222292023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",19348,99,0.89 [0.69-1.16],0.4065759859455544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19384,97,1.02 [0.69-1.52],0.9186722401471872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,22375,115,0.91 [0.72-1.14],0.3910933341753773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,22916,120,1.06 [0.86-1.31],0.5564142339040186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19980,101,0.92 [0.75-1.12],0.401311715039673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22955,118,0.88 [0.75-1.02],0.0931189179456994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22775,117,1.45 [1.00-2.12],0.0519518706330199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22775,117,1.10 [0.92-1.32],0.2917145529496796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22328,115,1.17 [0.83-1.65],0.3565053589296854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,19900,99,0.92 [0.66-1.29],0.6465892652982379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,22367,117,0.97 [0.83-1.13],0.6832890171826562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22775,117,1.44 [0.84-2.49],0.1845815137219931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,22796,117,1.71 [1.08-2.70],0.0220536133215302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,22367,117,0.89 [0.52-1.51],0.6672500028872865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,23141,119,1.46 [0.89-2.37],0.1326026767727425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,22985,119,1.23 [0.76-2.00],0.4077868684876876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,22375,115,1.23 [1.00-1.52],0.0539588011533731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,22367,117,1.14 [0.70-1.86],0.6064580828088253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,20043,98,1.14 [0.55-2.35],0.7300213291848885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,19967,101,1.01 [0.66-1.54],0.9618860685339938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19897,101,0.94 [0.54-1.65],0.8321360203237484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,19439,99,1.10 [0.93-1.31],0.2782400136238758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,22878,119,1.25 [0.72-2.19],0.4300539127610564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,23124,119,1.65 [0.96-2.83],0.0703768195267747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,22912,117,1.06 [0.97-1.14],0.1830094891101491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,19260,99,1.08 [0.62-1.88],0.7791874499121549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,22375,115,1.27 [0.89-1.82],0.19257347637019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,19439,99,0.81 [0.51-1.31],0.3932198337383871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,22868,121,1.04 [0.86-1.26],0.6779678355048504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,22367,117,1.16 [0.99-1.36],0.0675243258874355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,19384,97,0.92 [0.69-1.23],0.5908389240478764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,19440,96,0.77 [0.42-1.40],0.3824253975911524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,22699,117,0.60 [0.36-1.02],0.0606783775280551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,19498,94,1.13 [0.85-1.49],0.4154083470127608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,22984,120,1.33 [0.98-1.80],0.06318748118075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,19498,94,4.46 [2.26-8.81],1.6457774366863606e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,22886,120,3.37 [2.24-5.09],6.786689140754658e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,19931,101,1.33 [1.08-1.64],0.0064525424911469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,23052,120,1.28 [1.02-1.60],0.02971185349947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,19568,96,1.77 [1.34-2.32],4.6598075785587777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,22985,119,1.19 [0.74-1.90],0.4676125252202167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,22336,117,1.32 [0.88-1.98],0.1756105897717305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19569,99,0.94 [0.69-1.29],0.7133337654467489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23124,119,2.15 [1.55-2.99],4.776919774978712e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",22775,117,1.06 [0.80-1.40],0.705681409387312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",23120,121,0.96 [0.77-1.20],0.7285578243873583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,22462,118,0.95 [0.73-1.24],0.7058107648416265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,22879,118,0.97 [0.81-1.17],0.7805428279073153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,19440,96,1.05 [0.74-1.50],0.7717011071558009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,19348,99,1.24 [0.85-1.83],0.2655598133642239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19897,101,1.15 [0.81-1.64],0.4247437324224996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19612,99,0.92 [0.66-1.29],0.6396331593907505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19348,99,0.91 [0.66-1.26],0.5777148842552025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,19298,99,1.38 [0.65-2.90],0.4022009665553788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,19439,99,1.08 [0.73-1.59],0.6960252967929939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19612,99,1.05 [0.77-1.42],0.7733056724155054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19498,94,0.92 [0.62-1.37],0.6868792266600068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,19298,99,0.68 [0.45-1.04],0.0727333227515462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,23024,120,0.78 [0.60-1.00],0.0514134444692505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22835,117,2.94 [1.72-5.01],7.388292801330709e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23120,121,0.82 [0.43-1.56],0.5480243756271677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22462,118,1.18 [0.80-1.74],0.4102267119384126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20004,98,1.70 [0.85-3.41],0.1360890164858693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,22835,117,1.27 [0.56-2.89],0.5653801110784282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,19384,97,1.31 [0.86-2.01],0.2090195396486452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19156,95,0.88 [0.48-1.63],0.6917767516432728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,19980,101,0.41 [0.17-0.98],0.0442597005773859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,19612,99,1.31 [1.00-1.71],0.0468441385241348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,23036,120,2.67 [1.45-4.92],0.0015867850213917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,19384,97,0.83 [0.52-1.31],0.4249881809222532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,19967,101,1.52 [1.36-1.70],6.04143154643918e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19298,99,0.85 [0.40-1.80],0.6755009797071212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19498,94,0.92 [0.70-1.20],0.5450252709059398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,19440,96,1.22 [0.86-1.73],0.2759064225573658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,19934,101,1.62 [1.24-2.12],0.0003834827216923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,22462,118,1.00 [0.76-1.32],0.9938048760353504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,22375,115,1.10 [0.78-1.55],0.5766966842478451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,19384,97,0.91 [0.56-1.48],0.6970052111240967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,20043,98,1.22 [0.57-2.61],0.6002986541270827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,19967,101,0.95 [0.79-1.14],0.599200749168314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,22367,117,1.07 [0.94-1.21],0.3207690544874995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19118,93,1.71 [1.26-2.30],0.0004680298967346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,19384,97,1.22 [0.85-1.73],0.2786270002242432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22835,117,1.75 [1.11-2.77],0.0162662976196965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,23189,120,2.03 [1.67-2.47],8.796290137745664e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,22927,121,0.75 [0.48-1.17],0.2040761405575137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,22375,115,1.49 [1.00-2.20],0.0491887579758623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,20004,98,1.16 [0.87-1.56],0.3125088404775343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,22333,117,1.28 [0.89-1.84],0.1762679628875636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,22367,117,1.34 [1.04-1.71],0.022893548885494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22367,117,0.96 [0.84-1.10],0.585579617776381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,23084,121,3.10 [1.84-5.22],2.0575281682987613e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,22835,117,1.24 [0.58-2.64],0.5834783111834572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,22704,117,1.42 [0.79-2.55],0.2431765924206437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,19350,99,0.86 [0.62-1.18],0.3359686657067178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,22375,115,1.05 [0.83-1.31],0.7033678301865764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,20004,98,0.89 [0.67-1.18],0.4331156204393455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,19961,98,0.80 [0.53-1.22],0.3080646192442525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,22506,117,1.51 [0.98-2.33],0.0625943769890019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,22874,118,2.00 [1.54-2.59],2.005517399183082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,22775,117,3.22 [1.76-5.91],0.0001560678023109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,22890,121,1.06 [0.96-1.16],0.2570026512783897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,22367,117,0.99 [0.89-1.09],0.771123375588247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,19568,96,0.78 [0.40-1.56],0.4875651179123821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,22375,115,0.79 [0.55-1.13],0.2028125889340801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,22927,121,1.17 [0.95-1.43],0.1354637677127086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,19980,101,1.28 [0.81-2.03],0.2920100428832817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,19980,101,0.93 [0.72-1.20],0.5678925805340637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,19568,96,0.80 [0.42-1.51],0.490862858405387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,19298,99,0.81 [0.53-1.23],0.3232704726686735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,19498,94,1.81 [1.29-2.55],0.0006775682980112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,19967,101,2.52 [1.41-4.48],0.0017334164391788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,19900,99,0.93 [0.76-1.14],0.4792036580961845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,19439,99,0.75 [0.47-1.19],0.2213449054535926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,19439,99,0.97 [0.79-1.19],0.7673682456322414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,19298,99,0.75 [0.51-1.09],0.135173707232474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,21936,113,2.92 [1.76-4.84],3.264634208722909e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,19530,96,2.31 [1.41-3.78],0.0008414846990335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,22775,117,1.38 [0.94-2.04],0.103500121552732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,19439,99,1.04 [0.55-1.94],0.913838036194658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,22478,115,1.28 [0.97-1.69],0.0856734637365028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,22876,120,1.01 [0.64-1.59],0.9632802466200648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,19348,99,0.83 [0.48-1.44],0.517012008139319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,22791,120,1.09 [0.82-1.46],0.5355449422468911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19568,96,1.02 [0.82-1.28],0.8357922105565817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22375,115,0.87 [0.60-1.27],0.4615183643572897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,19897,101,1.09 [0.82-1.45],0.5701143981548251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,19513,97,1.56 [1.14-2.14],0.0056933890516117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,20004,98,0.86 [0.65-1.13],0.2859843158335543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,23141,119,1.11 [0.80-1.54],0.5401114758469769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,19568,96,0.76 [0.56-1.03],0.0773037646920948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,19980,101,0.74 [0.58-0.95],0.0193481731880995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22367,117,1.03 [0.79-1.33],0.8351227618416935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19440,96,1.25 [0.90-1.73],0.178350485543159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,22912,118,1.28 [0.92-1.78],0.1409051768379399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,19498,94,0.63 [0.31-1.29],0.206505112840079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,19568,96,0.66 [0.38-1.15],0.1465732464006956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,19980,101,0.97 [0.75-1.25],0.7855469736665206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,23124,119,2.18 [1.11-4.28],0.0235865738198361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22868,121,0.96 [0.81-1.13],0.6044418222121462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,19900,99,0.77 [0.50-1.20],0.2478829503431302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",20004,99,1.94 [1.39-2.71],0.0001054972274581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,22789,117,0.77 [0.46-1.29],0.320206314232627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,19384,97,0.95 [0.71-1.28],0.7429932108069044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22200,115,0.95 [0.78-1.17],0.6372675914827711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,19568,96,0.52 [0.31-0.87],0.0128238411925158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,22879,118,0.93 [0.77-1.13],0.4623812891297751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,22835,117,1.01 [0.89-1.14],0.8801801929705326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,23120,121,1.25 [0.72-2.18],0.4349036096062775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,22775,117,0.66 [0.49-0.88],0.004922817201099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,19897,101,2.03 [1.51-2.73],2.595226466478664e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,19900,99,0.88 [0.56-1.37],0.5631700714904669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,20025,100,0.90 [0.59-1.36],0.6086021547172616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19900,99,0.96 [0.73-1.25],0.7479485212350245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,22375,115,1.85 [1.24-2.74],0.0024557833006606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,22316,120,1.65 [0.93-2.94],0.088648255635339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,19348,99,1.04 [0.78-1.38],0.7944715256817954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,19980,101,1.42 [0.92-2.19],0.1155173445713617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,19900,99,1.69 [1.26-2.26],0.0004052014584261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,22478,115,1.57 [1.23-2.01],0.000310964877618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,19897,101,1.59 [1.26-1.99],6.514221019253248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,22927,121,0.96 [0.84-1.09],0.4917357857636901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20004,98,1.03 [0.76-1.39],0.8626498156044575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",19980,101,0.57 [0.32-1.02],0.0596374523293376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19348,99,0.93 [0.64-1.35],0.6998494537750257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,22478,115,1.17 [0.87-1.57],0.2911775021173904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,22801,118,2.80 [1.52-5.17],0.0009532158400996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,19498,94,1.39 [0.98-1.98],0.0615276655629817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",22835,117,1.69 [1.36-2.09],1.4453192452474564e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,19190,99,0.90 [0.69-1.17],0.430639751050765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,22367,117,1.01 [0.83-1.22],0.9393788709442066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,19965,100,0.46 [0.26-0.82],0.0089333664957923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",19900,100,1.69 [0.71-4.03],0.2333353462289907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,22897,121,1.25 [1.04-1.49],0.0168324066168759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,22367,117,1.19 [0.97-1.46],0.0973034143406648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,19384,97,1.09 [0.86-1.38],0.4928152386424885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,22234,113,1.15 [0.91-1.45],0.2310749441516076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,19967,101,0.99 [0.91-1.08],0.8437541061071991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19612,99,0.85 [0.62-1.17],0.3172911239743819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,19440,96,0.90 [0.70-1.16],0.4072153898106557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,22801,118,1.75 [1.10-2.77],0.0173101949296942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,19612,99,0.95 [0.75-1.21],0.6997692548671699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,19384,97,1.02 [0.62-1.66],0.9522068286179118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,23012,120,1.66 [1.30-2.13],5.511720844513197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",22478,115,1.01 [0.84-1.21],0.9055517430317964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,23141,119,1.01 [0.63-1.62],0.9749973880873404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,22868,121,1.10 [0.86-1.40],0.4465617836957792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,22478,115,1.21 [0.99-1.48],0.0634362155127678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,19298,99,1.20 [0.85-1.70],0.3067108526603354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19384,97,0.90 [0.63-1.28],0.5617474112822982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23050,120,1.03 [0.83-1.28],0.7657502252254971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,23120,121,1.20 [1.07-1.34],0.0019892163149463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",22912,118,0.95 [0.77-1.19],0.6788459228551414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,23086,120,1.99 [1.60-2.48],5.854055614795346e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,22912,118,2.69 [1.73-4.18],1.0594002908880104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,23050,120,0.76 [0.61-0.96],0.0198810745299666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,23120,121,1.02 [0.78-1.35],0.8761260979839277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,20004,98,0.98 [0.81-1.18],0.8418606899538003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,19384,97,0.85 [0.56-1.30],0.4587854314648247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,23141,119,0.98 [0.72-1.32],0.8848831392496901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,19439,99,0.93 [0.63-1.35],0.6907794407821675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,19348,99,0.82 [0.56-1.20],0.3025509777522024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,19900,99,0.93 [0.59-1.45],0.7440774027103931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,23091,121,1.03 [0.87-1.22],0.7159351371405109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,19967,101,1.09 [0.81-1.48],0.5712981784477362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,22478,115,0.90 [0.63-1.26],0.53064433854192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,19568,96,2.77 [1.40-5.47],0.0032750573747745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,19967,101,0.97 [0.61-1.55],0.9102876906813802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,20004,98,2.52 [1.18-5.38],0.0164447905796171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,22868,121,1.01 [0.82-1.23],0.950000968721975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,23141,119,2.81 [1.85-4.25],1.08664823052056e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,19829,99,0.70 [0.40-1.24],0.222585986830743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22367,117,0.92 [0.74-1.15],0.4519559758346416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,19967,101,1.09 [0.84-1.41],0.532542250546334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,19439,99,0.94 [0.70-1.25],0.6590459098614118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,19384,97,1.27 [0.81-2.00],0.2983088616814051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,19930,101,1.59 [1.18-2.16],0.0026994978082535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,19980,101,1.37 [0.97-1.94],0.0757761850959626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,22478,115,1.95 [1.14-3.34],0.0154990344403268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19980,101,2.42 [1.31-4.47],0.0045876338811584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22809,119,1.92 [1.25-2.94],0.0029928624008581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22868,121,2.89 [1.77-4.71],2.1593038270086635e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,23120,121,1.11 [0.78-1.59],0.5567638529466532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,19535,96,0.97 [0.69-1.38],0.8846558203909647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19498,94,1.13 [0.75-1.68],0.5633485768379727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19384,97,1.29 [0.86-1.96],0.2209823089800513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,19263,99,0.98 [0.64-1.50],0.9321831283402152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,22664,120,1.52 [1.11-2.09],0.0096398198147934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,22375,115,1.67 [1.28-2.18],0.000146822524938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,19440,96,0.98 [0.75-1.28],0.889250679717785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,22660,117,1.68 [1.20-2.35],0.0026177029768102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22410,115,1.14 [0.92-1.42],0.229017288668796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19980,101,1.04 [0.70-1.56],0.8465109709267289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,23141,119,0.98 [0.79-1.23],0.8735505768221328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,22367,117,0.47 [0.30-0.74],0.0010609567158457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,19726,98,1.00 [0.81-1.24],0.9895325748013776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,19571,99,1.01 [0.82-1.24],0.9232643685200402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19498,94,0.69 [0.37-1.31],0.2560692161066593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,19917,97,1.07 [0.57-2.00],0.8352178167296491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,19498,94,0.90 [0.71-1.13],0.3650435786209931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22835,117,1.88 [1.25-2.82],0.0024401597727833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23120,121,0.87 [0.54-1.40],0.5567926740081135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19439,99,1.17 [0.62-2.19],0.6257401655989492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,19498,94,0.99 [0.80-1.23],0.9342045652199478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22868,121,1.64 [1.09-2.46],0.0175459762424484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19967,101,1.39 [1.04-1.88],0.0283277019519206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19384,97,0.65 [0.41-1.03],0.0640676238939674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19498,94,1.56 [1.04-2.33],0.0302485612589898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,22265,114,1.02 [0.79-1.30],0.8982960878809332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,22988,120,1.03 [0.82-1.29],0.8137727327699887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,19897,101,1.17 [0.66-2.06],0.5983439416063147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,22564,119,1.14 [0.89-1.47],0.3074798257212171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,23120,121,1.42 [0.93-2.16],0.1030740907567282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22714,119,3.10 [1.95-4.93],1.571653847369904e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,19348,99,1.17 [0.95-1.44],0.1368056928498081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,19348,99,0.97 [0.59-1.59],0.8981273192593658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",22985,119,1.20 [0.93-1.56],0.1588641495714832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,22752,119,2.71 [1.51-4.86],0.0008673099603601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,23189,120,1.66 [0.78-3.51],0.184974494212874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,22462,118,0.94 [0.76-1.16],0.5600385693662431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,22798,119,2.74 [1.69-4.43],3.986682689856125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,23189,120,1.15 [0.68-1.93],0.5955752707229787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,23189,120,1.31 [0.69-2.49],0.4126439677629309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,22868,121,0.96 [0.70-1.31],0.8079367095528354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,22927,121,1.73 [1.21-2.48],0.0027927490872432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,22835,117,1.04 [0.44-2.47],0.9306825662551528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,19612,99,0.71 [0.41-1.23],0.2262039699636233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22375,115,1.13 [0.79-1.61],0.5169988533573415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",19498,94,1.25 [0.95-1.64],0.1123831223690079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,23141,119,0.51 [0.09-2.69],0.4241646658602979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,23120,121,1.44 [1.00-2.06],0.0487112577369196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19406,97,3.22 [2.23-4.66],5.559604123189331e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19612,99,0.96 [0.65-1.41],0.8313072790773104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19612,99,1.08 [0.65-1.79],0.7700576698559131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,19900,99,1.30 [0.65-2.62],0.4607754501042913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,22462,118,1.08 [0.94-1.25],0.2769325420166928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,23024,120,2.03 [0.93-4.42],0.076088971860016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,22775,117,1.41 [1.04-1.90],0.0248955106266428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,22375,115,1.46 [1.05-2.04],0.0248968110910885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,19348,99,1.03 [0.77-1.38],0.8385910325987941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,22868,121,1.18 [0.79-1.78],0.4185496036184227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,19384,97,1.14 [0.70-1.84],0.5979660624540368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,19440,96,0.78 [0.48-1.29],0.3368537420927988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,19980,101,0.79 [0.57-1.10],0.1625307536263448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19348,99,0.81 [0.52-1.27],0.3610247674436422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20004,99,1.01 [0.48-2.14],0.9841911607708458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,22835,117,1.54 [0.91-2.61],0.1048327574207171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19384,97,0.76 [0.46-1.25],0.2781463122516905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,22912,118,1.83 [0.90-3.73],0.093780856439806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,23148,120,1.14 [0.99-1.31],0.071891425555479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,23146,120,1.46 [1.12-1.91],0.0050346457544041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,22980,119,0.75 [0.43-1.32],0.3209982667214401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,22606,115,2.34 [1.74-3.16],2.4196874769430364e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,22797,119,1.24 [0.72-2.14],0.4394609082364079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,23189,120,2.29 [1.54-3.41],4.735687938889853e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22927,121,3.44 [2.32-5.10],7.276578451114779e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,19439,99,1.02 [0.80-1.31],0.8731955262044384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,19384,97,0.77 [0.52-1.15],0.2039384367386305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,20002,98,1.61 [0.94-2.77],0.0829863963855246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,19298,99,1.06 [0.87-1.29],0.5902303977751187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,19498,94,0.67 [0.38-1.19],0.1748182071104848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,22835,117,1.94 [1.47-2.57],3.7656532323452383e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,22927,121,1.92 [1.16-3.15],0.0106194847652619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,20004,98,1.38 [1.10-1.72],0.0053546013307916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,22868,121,0.97 [0.81-1.17],0.7634419790900532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,22367,117,1.08 [0.91-1.28],0.3724243316053081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,22462,118,1.26 [1.08-1.47],0.0041765781001742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,22462,118,1.09 [0.85-1.41],0.4859858349365288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,23024,120,3.20 [2.12-4.82],2.5582313450099826e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,22462,118,0.80 [0.60-1.08],0.1516963599336619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,22835,117,1.23 [1.00-1.51],0.0475053863070276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,23141,119,1.36 [1.02-1.82],0.0347690554272148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,22462,118,1.19 [0.77-1.84],0.4255654108731836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,19439,99,0.93 [0.56-1.55],0.7871963658420693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,22462,118,0.87 [0.59-1.28],0.471111086610084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,22623,114,1.46 [0.66-3.21],0.3488866721617343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,19348,99,0.61 [0.31-1.22],0.1613166831036514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,22868,121,2.71 [1.77-4.15],4.755016417049413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,22462,118,1.77 [1.11-2.83],0.0174492053956996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,23141,119,1.51 [1.08-2.11],0.0170987024146374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,22435,118,1.53 [1.12-2.09],0.0079821360930128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,22462,118,1.42 [1.17-1.72],0.0004484891753859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,22462,118,1.01 [0.61-1.67],0.982417918227013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,22462,118,1.08 [0.90-1.31],0.4081765929506964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,22912,118,1.63 [1.11-2.38],0.0119398840141705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,22585,121,0.89 [0.66-1.20],0.4404257890452828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,22838,119,1.72 [1.27-2.32],0.0004466878972886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,22980,119,2.96 [1.87-4.69],3.783337921329857e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,23141,119,3.22 [2.08-4.99],1.4849534180841904e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,22626,117,0.96 [0.87-1.06],0.472941179075887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,22356,119,1.78 [1.46-2.17],1.4934493785493623e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,22462,118,1.04 [0.77-1.41],0.7834980376123277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,22357,118,1.26 [0.97-1.64],0.0821903774230232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,22874,118,3.84 [1.91-7.72],0.0001630889472483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,22885,119,1.46 [0.63-3.40],0.3755235818157314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,22912,118,0.54 [0.36-0.82],0.0035146284313347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,23117,120,2.25 [1.58-3.21],7.672160400439122e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,22462,118,0.59 [0.40-0.87],0.0071451660589657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,22876,120,1.52 [1.20-1.92],0.00057601149399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,22462,118,1.20 [0.70-2.06],0.5036933262417824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,22462,118,0.92 [0.65-1.31],0.6589776777305477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,22462,118,1.01 [0.69-1.48],0.9613830936618368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,19439,99,1.76 [1.22-2.53],0.00255906655411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,19439,99,0.92 [0.63-1.34],0.6731699383141416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,19897,101,1.91 [1.59-2.30],9.577593205627752e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,22462,118,1.18 [0.83-1.66],0.3542743979486021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,22462,118,0.95 [0.66-1.35],0.7586003075787161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,19230,99,1.54 [0.92-2.57],0.1010917409667323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,22738,116,2.53 [1.76-3.62],4.420045775646745e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,22462,118,1.07 [0.71-1.60],0.7501310958416734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,19897,101,1.44 [1.04-2.00],0.0270964429891301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,19298,99,1.19 [0.84-1.68],0.3243808985341104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,19439,99,0.80 [0.53-1.19],0.266292286291137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,19357,99,1.26 [0.77-2.06],0.350967740173792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,22868,121,1.88 [1.38-2.56],5.453110856460866e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,22462,118,1.34 [0.88-2.03],0.1697088660555148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,22339,114,1.10 [0.68-1.76],0.7041297039243583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,19439,99,1.11 [0.79-1.55],0.5517287508326834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,19353,99,1.33 [1.05-1.69],0.0192681998428257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,22462,118,1.20 [0.71-2.02],0.4921765633414887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,22462,118,1.13 [0.92-1.39],0.2431844848808994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,22868,121,2.62 [1.84-3.72],7.816580478937151e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,22462,118,1.05 [0.94-1.16],0.4240500746224227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,22868,121,1.05 [0.79-1.41],0.720264209932479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,22835,117,1.47 [1.28-1.70],1.197242123062092e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,22754,119,1.75 [1.08-2.83],0.0232061702354162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,22927,121,4.28 [1.76-10.43],0.0013666480900821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,22868,121,0.94 [0.73-1.21],0.623585137255793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,22912,118,0.83 [0.62-1.11],0.2100133883986962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,19612,99,1.05 [0.77-1.43],0.7796325539900435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22343,115,1.02 [0.76-1.37],0.8889090052524651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,19897,101,1.68 [1.25-2.25],0.0005049307059209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,22775,117,0.92 [0.70-1.23],0.585968483926611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,19967,101,0.88 [0.61-1.25],0.46423837910589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,19348,99,0.98 [0.52-1.88],0.9594251110323362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,22328,115,1.13 [0.78-1.62],0.5210459512195076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,19568,96,1.73 [1.21-2.46],0.0024624824130376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,22912,118,1.33 [0.90-1.97],0.1555308146446902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,22835,117,1.17 [0.87-1.57],0.2884990447462021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19498,94,1.06 [0.75-1.51],0.7266625030056625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19980,101,0.68 [0.40-1.16],0.1546261378908409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22835,117,0.99 [0.83-1.17],0.8838019895683198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,19967,101,0.84 [0.62-1.13],0.2502537962259989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,19897,101,1.04 [0.78-1.39],0.7957997722938034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,19900,99,1.33 [1.11-1.60],0.0025432841204279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,19439,99,2.57 [0.83-7.91],0.1004116144372638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,22738,117,1.10 [0.91-1.33],0.3210793252260883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22835,117,1.47 [1.12-1.93],0.0053062943806243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22478,115,1.08 [0.90-1.29],0.4287353133519607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,22462,118,0.96 [0.75-1.23],0.7356797190448301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,22868,121,0.98 [0.83-1.14],0.765407249630457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22057,113,0.96 [0.62-1.49],0.8466110692161173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,22868,121,1.71 [1.14-2.57],0.0088762059111272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,20004,99,1.12 [0.75-1.66],0.5751865396012071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,19759,99,0.90 [0.74-1.09],0.2806316316364282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,22868,121,0.64 [0.40-1.02],0.063200879970065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,19568,96,0.39 [0.22-0.69],0.00139737579257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,22912,118,2.31 [1.22-4.38],0.0105864060820581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,22868,121,0.70 [0.50-0.98],0.0389797522351648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,19439,99,1.16 [0.73-1.85],0.5285661086335727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,22912,118,0.68 [0.40-1.17],0.165507705386137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,23120,121,0.46 [0.18-1.18],0.1063961518984082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,19612,99,0.99 [0.69-1.42],0.9546726494860815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,22871,119,1.06 [0.49-2.30],0.8725474228470667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,22367,117,1.22 [0.82-1.81],0.3300669705319798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,22478,115,1.08 [0.92-1.26],0.3567263663658617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,22750,119,0.72 [0.40-1.29],0.268378296676762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,22985,119,0.90 [0.58-1.40],0.6375855179329281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,22462,118,0.89 [0.51-1.57],0.6968879077827874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,23120,121,1.21 [0.85-1.70],0.2878759486336067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,20004,99,1.62 [0.98-2.69],0.0602630882765209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20043,98,0.90 [0.30-2.67],0.8506108444159676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22980,119,1.53 [0.99-2.38],0.056884263977199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20043,98,0.88 [0.41-1.85],0.7268171158427083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19897,101,0.99 [0.66-1.50],0.9723809884941654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,22868,121,1.23 [0.95-1.61],0.1196969925631773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,19384,97,1.03 [0.77-1.39],0.8334567711231675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19498,94,1.04 [0.79-1.36],0.7875699137646719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19348,99,0.84 [0.53-1.33],0.4611312801306044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22375,115,1.43 [1.05-1.94],0.0221269118954974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,19298,99,0.82 [0.53-1.29],0.3955062380883485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,23124,119,2.13 [1.20-3.77],0.0097532834237583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,19568,96,1.06 [0.72-1.56],0.7737854604105524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,22462,118,1.19 [0.92-1.55],0.1901965960132033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19298,99,0.82 [0.55-1.21],0.3178767534540996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,19900,99,0.90 [0.71-1.13],0.3459283244093101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,22462,118,1.35 [1.08-1.69],0.0085792342118199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22835,117,0.88 [0.62-1.25],0.4727602007858441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,19900,99,0.98 [0.81-1.19],0.8506707413803519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,19348,99,0.62 [0.39-0.99],0.0463247671625006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,19440,96,1.05 [0.83-1.35],0.6693582426293088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,22375,115,0.81 [0.55-1.20],0.2919051580707762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,19594,101,1.41 [0.95-2.09],0.0877650639779893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,19439,99,1.11 [0.91-1.36],0.2982125525594479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,22985,119,0.95 [0.51-1.78],0.8684283005360622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,22375,115,0.94 [0.59-1.50],0.7980035654057118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,19298,99,1.07 [0.83-1.39],0.5859404181280897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,19498,94,1.12 [0.82-1.53],0.4609777133291668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,19967,101,1.04 [0.57-1.90],0.90759995583866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,19612,99,1.32 [1.04-1.69],0.0243581574213725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,19612,99,1.11 [0.57-2.15],0.7532033960859725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,19897,101,1.01 [0.74-1.39],0.9289675686397052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,19384,97,1.65 [1.22-2.24],0.001052347641352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,19348,99,0.98 [0.76-1.26],0.8683801138100207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,19384,97,1.06 [0.90-1.25],0.4578038567215657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,22835,117,0.98 [0.79-1.20],0.8137135837836047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19897,101,1.09 [0.87-1.36],0.4758402320437949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22367,117,1.09 [0.88-1.35],0.4359241652957919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19900,99,1.03 [0.92-1.15],0.6403573324925658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22367,117,0.96 [0.83-1.10],0.5411339949322901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19298,99,0.83 [0.62-1.10],0.1944714098992409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,19348,99,0.89 [0.61-1.30],0.5444133868196799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,22375,115,1.10 [0.73-1.66],0.6325684183007882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,22942,119,0.78 [0.45-1.36],0.3797722955514461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,22927,121,0.46 [0.32-0.68],9.791521561001429e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,22375,115,1.03 [0.82-1.29],0.7966271178377206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,19348,99,0.95 [0.58-1.58],0.8535406293131068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,19980,101,0.69 [0.44-1.09],0.1116285563737955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,22663,118,0.94 [0.82-1.07],0.3347979195606086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,22907,119,1.46 [0.98-2.19],0.061866904558232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,22773,118,2.19 [1.50-3.19],4.333630976921317e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,22367,117,1.08 [0.96-1.21],0.1839761381378141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,22450,113,1.88 [1.30-2.71],0.0007176581693886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,23120,121,1.73 [1.25-2.41],0.0010161484840707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,19865,101,1.00 [0.68-1.45],0.9864220193676134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,20004,99,0.90 [0.64-1.26],0.5447903662883424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,23120,121,1.29 [1.01-1.65],0.0438455502237958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,22956,119,1.26 [0.74-2.14],0.4035286329675236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,19046,93,1.24 [0.73-2.09],0.4283372089617278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,22149,114,1.63 [1.04-2.56],0.0346963792164601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,19632,95,0.40 [0.19-0.87],0.020002279544193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,23141,119,1.47 [0.97-2.25],0.0722857471736745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19348,99,1.04 [0.76-1.43],0.7947420862087736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,23141,119,1.25 [0.88-1.77],0.2105807472095423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19439,99,1.28 [0.90-1.83],0.1698808944216943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,19967,101,1.35 [0.87-2.09],0.1800661571103928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",21637,111,1.21 [0.66-2.19],0.5376963600733278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",19384,97,0.96 [0.55-1.67],0.8839793697822875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",22835,117,1.39 [1.17-1.66],0.0002464267200646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",22834,121,1.51 [1.22-1.87],0.000141396667555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",22375,115,1.27 [0.91-1.77],0.1676704971046498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",19384,97,0.91 [0.56-1.48],0.6979059920944428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",19348,99,1.13 [0.85-1.49],0.4051810007358178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,22886,121,1.01 [0.76-1.35],0.9431322780902996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,23141,119,1.83 [1.33-2.53],0.0002475111623418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,22985,119,1.24 [0.70-2.19],0.4574503813301657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20004,98,1.05 [0.85-1.31],0.6467827945523563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,19866,100,0.93 [0.62-1.37],0.7011320498731026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,22927,121,0.95 [0.74-1.22],0.6969938445708245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,22835,117,0.99 [0.66-1.48],0.958572359367546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22916,119,2.21 [1.62-3.03],7.545872529733876e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22775,117,1.00 [0.85-1.18],0.9799758292588316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,19384,97,1.16 [0.86-1.57],0.337255063366574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,23024,120,1.57 [0.98-2.52],0.0613807516846664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,19498,94,0.73 [0.38-1.40],0.3380748689245075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,19420,96,1.08 [0.58-2.02],0.8105428147983893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,22225,115,1.56 [0.62-3.92],0.3428547496472006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,23103,119,1.79 [1.37-2.32],1.3792719815665814e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,19897,101,0.90 [0.56-1.46],0.6727037458460664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,22462,118,1.07 [0.77-1.49],0.686419857812147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,19897,101,0.65 [0.45-0.93],0.018417889565253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,23141,119,0.91 [0.73-1.13],0.3902074225581042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,22835,117,1.01 [0.88-1.16],0.9057312269344856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,19439,99,0.91 [0.72-1.16],0.4523319443398875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,22728,117,2.84 [1.88-4.28],6.178933095195655e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,22980,119,1.50 [1.17-1.92],0.0014815783173071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,23124,119,1.21 [0.97-1.50],0.0923157548022605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,20025,100,0.76 [0.33-1.73],0.5068161024577078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,19980,101,1.11 [0.85-1.45],0.4397514371656581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,22203,117,1.79 [1.25-2.56],0.0015772043992407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,20004,99,1.43 [0.97-2.09],0.0697917810411993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,22971,119,0.95 [0.69-1.30],0.7417340985370854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19980,101,0.89 [0.73-1.09],0.2478893065523566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,20004,98,0.99 [0.73-1.35],0.9669806543269954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,23084,121,1.05 [0.78-1.41],0.7572144056819352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,18891,94,1.24 [0.94-1.64],0.1345393978026074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,19348,99,1.16 [0.94-1.44],0.1702230473257681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,19980,101,1.20 [0.74-1.94],0.4673242873523054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,22927,121,1.22 [0.94-1.60],0.1369031141505747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,22927,121,1.27 [0.81-1.98],0.3005349965394909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,19980,101,1.13 [0.79-1.63],0.4950965699227631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,22927,121,1.49 [0.94-2.36],0.0892111046469366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,22968,119,2.16 [1.32-3.56],0.0023057646517762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,20043,98,1.14 [0.60-2.18],0.6867630678266662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,22916,119,2.02 [1.54-2.65],3.517953609889823e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,22848,119,1.46 [1.01-2.11],0.0468026245489569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,23124,119,0.94 [0.72-1.24],0.6774310405776787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,22912,120,3.87 [2.50-6.00],1.352802361930846e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,23024,120,2.58 [1.70-3.92],8.232847615185568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,22367,117,0.99 [0.81-1.21],0.9079543527550668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22948,120,1.04 [0.79-1.36],0.7884038588340664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,22375,115,1.19 [0.89-1.58],0.2405651579566285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,22868,121,1.19 [0.63-2.23],0.5917387866887538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22912,118,1.43 [0.89-2.29],0.142091143261712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20004,99,1.01 [0.88-1.16],0.9133664364407093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19384,97,1.11 [0.79-1.55],0.5578600186374758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22890,121,2.29 [1.37-3.81],0.0014857659351248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20004,98,1.09 [0.83-1.43],0.539847887568774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23189,120,1.43 [0.80-2.58],0.2289164771459076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23074,120,1.07 [0.67-1.71],0.7725429652005062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22462,118,1.58 [1.10-2.28],0.0144790655874742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23189,120,1.21 [0.95-1.55],0.1304589289191522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,19498,94,1.42 [1.05-1.91],0.0231140043274274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,19857,99,1.27 [0.96-1.68],0.0886498314940813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,19967,101,2.52 [1.40-4.55],0.0021604063010969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,19980,101,1.49 [0.99-2.26],0.0587694758360024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,19348,99,0.89 [0.64-1.25],0.5083872620873303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",19498,94,1.01 [0.80-1.28],0.9427185508461275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),19543,94,1.06 [0.94-1.18],0.3489701607759222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22835,117,1.51 [1.19-1.92],0.0007678526790286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,22927,121,1.72 [1.19-2.47],0.0035834696983874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,22222,115,1.38 [1.05-1.82],0.0201838004809931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,19384,97,0.89 [0.66-1.20],0.449200636368359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19384,97,1.03 [0.78-1.37],0.8293170723189118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19440,96,0.59 [0.34-1.01],0.0548450488793562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,20043,98,3.51 [1.83-6.75],0.0001608773941701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23050,120,1.35 [0.85-2.14],0.2033339871606518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19360,99,1.16 [0.62-2.17],0.6521984377948801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,22835,117,1.55 [0.86-2.80],0.1486738544272289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,22927,121,2.28 [1.49-3.48],0.0001420940567503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,19440,96,1.05 [0.60-1.84],0.8674034188829257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,19440,96,1.14 [0.94-1.39],0.1857860765382276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23124,119,1.06 [0.81-1.39],0.6692591835978257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,22835,117,2.14 [1.56-2.93],2.3701403618611083e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19900,99,0.91 [0.58-1.45],0.6967786675991904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,19440,96,1.16 [0.78-1.72],0.4557956509594463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,20004,98,0.96 [0.63-1.48],0.8598250470073665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19897,101,0.90 [0.60-1.35],0.6236760407129643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,22462,118,0.45 [0.30-0.69],0.0002070682255229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19440,96,1.01 [0.62-1.62],0.9794672177516894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19980,101,0.90 [0.44-1.84],0.7820856561740858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,22367,117,0.90 [0.67-1.22],0.514119474408568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,19612,99,0.79 [0.59-1.06],0.1127450860673006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,22868,121,1.70 [1.17-2.49],0.0058060706806678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,22868,121,1.23 [0.83-1.82],0.2922749703583978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,23120,121,1.33 [1.05-1.69],0.0165276962707668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,19897,101,0.68 [0.36-1.28],0.2306043877228119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,23189,120,2.25 [1.40-3.61],0.0008395392456617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,22367,117,1.28 [0.98-1.65],0.0650226799062342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,22808,119,3.77 [2.35-6.05],4.038109521015873e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,22462,118,1.07 [0.73-1.56],0.7381167045805276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,19897,101,1.08 [0.70-1.66],0.7316932087666457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,22666,116,0.91 [0.70-1.18],0.4552665166075996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,22801,120,1.85 [1.29-2.65],0.0008371184434985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,22868,121,1.22 [0.80-1.87],0.3500737930736696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,22658,113,1.33 [0.73-2.39],0.3487288106398876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,22775,117,2.02 [1.36-3.02],0.0005532919172535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,22367,117,1.03 [0.75-1.41],0.863233327631878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,22835,117,0.94 [0.77-1.15],0.5760854093448595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,22375,115,1.18 [0.97-1.45],0.1033199320470344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,22806,118,1.46 [0.93-2.31],0.1020152424211279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,22367,117,1.56 [1.24-1.97],0.0001740590862721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,19348,99,0.97 [0.80-1.18],0.7773738133655735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19440,96,0.93 [0.76-1.14],0.4795683512732334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20043,98,1.23 [0.45-3.35],0.6844312154917838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,19298,99,0.78 [0.43-1.40],0.4054351054722793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,19568,96,0.78 [0.58-1.04],0.0883989994136965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,19498,94,1.25 [0.80-1.93],0.3257405195651587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22690,117,1.49 [1.18-1.89],0.0009392377382704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,22367,117,0.73 [0.45-1.16],0.1824754942655596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,19440,96,0.91 [0.59-1.39],0.6499249396024138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,19612,99,0.98 [0.77-1.23],0.843094349514215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,22367,117,0.98 [0.68-1.41],0.9188975445973732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,20004,98,2.29 [1.39-3.78],0.0011625540043976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,19897,101,1.25 [0.91-1.73],0.1641151676387728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19498,94,1.64 [0.77-3.50],0.2041578484126397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,20004,98,1.33 [0.96-1.86],0.0894081560144028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19298,99,0.86 [0.58-1.28],0.4705637960891375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,23024,120,0.97 [0.85-1.11],0.6835947989032416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,22985,119,1.90 [1.09-3.29],0.0227486716731432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,19384,97,1.05 [0.78-1.42],0.730289283923369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19348,99,0.54 [0.29-1.03],0.0608841706569606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19384,97,0.73 [0.48-1.12],0.1501769065397415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,19967,101,1.21 [0.82-1.78],0.3462944071809106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19900,99,0.82 [0.60-1.12],0.2043990739503302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22868,121,0.95 [0.81-1.12],0.5228185886491687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22367,117,0.96 [0.80-1.14],0.6031626123031519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22728,117,0.95 [0.82-1.11],0.5076516120063789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,19298,99,1.39 [0.98-1.98],0.0647740321886983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,22868,121,0.97 [0.66-1.42],0.8776096568943321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,19612,99,0.94 [0.72-1.22],0.6346180178309807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,19298,99,1.00 [0.86-1.16],0.9617176499463158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,22375,115,1.37 [1.00-1.88],0.0536597090302014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,22927,121,1.85 [1.00-3.43],0.0503458431482198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",19530,96,0.92 [0.72-1.16],0.4740198144776447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,22728,117,1.11 [0.55-2.24],0.76033264207825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,22958,120,2.49 [1.46-4.25],0.0008240578775971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,22738,117,1.30 [0.77-2.21],0.3217800828974337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,22367,117,1.02 [0.85-1.23],0.8091463506943419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,22375,115,0.98 [0.83-1.15],0.7982855499740334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,23189,120,0.93 [0.67-1.30],0.6819926194344423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,19748,96,0.98 [0.82-1.17],0.8237618528838268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,22980,119,1.10 [0.69-1.76],0.6816946333993272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19980,101,0.69 [0.42-1.14],0.1492523940183613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,19439,99,1.00 [0.81-1.24],0.9868183257417834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,22835,121,1.18 [0.81-1.72],0.3963382078502975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,19900,99,0.75 [0.33-1.69],0.4844537254026819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22775,117,0.84 [0.67-1.06],0.1366013721301771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",19908,100,0.87 [0.53-1.42],0.5858681437654611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,22922,118,1.30 [0.98-1.71],0.0703100183967808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,19440,96,0.71 [0.37-1.36],0.2987077868663153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19498,94,1.01 [0.81-1.27],0.9146328063526784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,22367,117,1.01 [0.81-1.26],0.921005944059787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,19384,97,0.92 [0.60-1.42],0.7129159946761898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,22916,119,1.09 [0.71-1.65],0.7014445323744105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,19384,97,0.70 [0.35-1.42],0.3204531067669095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,23117,120,2.38 [1.15-4.94],0.0200756938999303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,20004,98,1.40 [0.72-2.71],0.3163155454225457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,19568,96,0.81 [0.33-1.97],0.6435805709271558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,19900,99,1.15 [0.87-1.51],0.3175441191684529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,22927,121,0.77 [0.68-0.88],0.0001031531068011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,22916,119,0.62 [0.36-1.07],0.0847748503735939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,23141,119,2.50 [1.40-4.45],0.0019390799147709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,22912,118,0.96 [0.84-1.10],0.565631575905998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,22973,118,0.53 [0.23-1.22],0.1349747401559454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,22375,115,1.09 [0.62-1.89],0.7709294729112622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22868,121,1.05 [0.86-1.28],0.6586606765872558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,23084,121,1.02 [0.77-1.35],0.8803939269603549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,22478,115,0.69 [0.46-1.02],0.0651615575551951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,19440,96,0.91 [0.66-1.26],0.5808069071846917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,19568,96,1.84 [0.98-3.45],0.0574330668174006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,23189,120,1.18 [0.80-1.75],0.4068466155161553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,22912,118,1.43 [0.99-2.06],0.0569761075258318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,22984,120,0.97 [0.80-1.17],0.7546803577822222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22868,121,0.97 [0.85-1.11],0.6553373012097188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,22985,119,1.15 [0.74-1.77],0.5315462935987272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,19440,96,0.96 [0.72-1.30],0.8092878993350074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22868,121,1.07 [0.95-1.20],0.2694524541865021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,22884,118,0.97 [0.76-1.24],0.8253499743256131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,22462,118,1.49 [1.10-2.01],0.0094899018039338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19897,101,0.94 [0.79-1.13],0.5218086261538954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,19967,101,0.96 [0.78-1.18],0.6975960794652152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,22775,117,0.98 [0.82-1.17],0.82304532810851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,19439,99,1.12 [0.71-1.77],0.6208468908397076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,19298,99,1.00 [0.75-1.32],0.9841146766110808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,22868,121,1.10 [0.91-1.32],0.3261734690397846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,22835,117,1.55 [1.29-1.85],1.777161957675848e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,22025,114,1.18 [0.97-1.44],0.0903070936120322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,22886,120,1.44 [1.14-1.83],0.0021533647740456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,22931,119,1.99 [1.51-2.62],8.090855785850361e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,22375,115,1.27 [0.77-2.11],0.3522424054836417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,20004,98,1.15 [0.82-1.62],0.4058534108943218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,22912,118,1.58 [1.16-2.16],0.0040656841288884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,22440,115,2.44 [1.70-3.50],1.3210294223062292e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,23087,119,1.39 [1.13-1.72],0.0019137311406776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,22871,118,1.42 [1.08-1.86],0.0109016591547848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19384,97,1.24 [0.84-1.84],0.2838238928738594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,19440,96,0.83 [0.57-1.22],0.3504469219780129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,19612,99,0.93 [0.60-1.45],0.7604139838648805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,22897,121,1.20 [1.05-1.38],0.0084946277285307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,19568,96,0.98 [0.73-1.32],0.8989859835044348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,23120,121,1.13 [0.68-1.86],0.6335716161029329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,19967,101,0.97 [0.49-1.94],0.933975077296076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,19612,99,1.21 [0.80-1.82],0.3653532004059467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,19298,99,1.33 [0.82-2.13],0.2463933953681087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,19298,99,0.93 [0.71-1.22],0.5973010126362883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,22478,115,1.05 [0.83-1.31],0.7006265602339758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,22835,117,0.93 [0.77-1.14],0.4993108348489334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22984,120,0.95 [0.77-1.17],0.6117556902669163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,22912,118,1.32 [0.98-1.79],0.0718382430163561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,19854,101,0.92 [0.59-1.42],0.6915277460297455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,20025,100,4.71 [2.68-8.28],7.606592356877116e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,19440,96,0.89 [0.66-1.19],0.4246381537901553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",19384,97,1.41 [1.00-1.99],0.0470829178108188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",19980,101,1.04 [0.62-1.74],0.8964956171255005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",22375,115,1.32 [0.73-2.38],0.3542447846186919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",19263,99,2.12 [1.16-3.87],0.0143801385043734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19980,101,1.01 [0.77-1.33],0.9199868737739209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",19439,99,1.38 [0.80-2.36],0.2435967575108898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,22802,117,1.51 [1.20-1.90],0.0004333046210638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,19440,96,0.63 [0.35-1.13],0.122041684889016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,22834,119,1.64 [1.30-2.07],2.6738061365249207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,23124,119,2.42 [1.71-3.42],5.271007966598943e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22985,119,0.99 [0.79-1.24],0.9098066324923764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,19719,97,1.46 [0.94-2.25],0.0900735442642917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,22478,115,0.61 [0.44-0.85],0.0035914527944427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,19439,99,0.94 [0.75-1.17],0.5881777096580127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19967,101,1.09 [0.54-2.21],0.8058975482183465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19612,99,0.99 [0.83-1.18],0.9044486978700784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",19900,99,0.92 [0.73-1.15],0.4515772223959944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,22478,115,0.77 [0.44-1.35],0.3599715047335878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,19384,97,0.76 [0.52-1.10],0.14641812949742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,19900,99,0.99 [0.83-1.18],0.8977274301266125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,19897,101,1.03 [0.84-1.25],0.7810476312602526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,19612,99,1.65 [1.31-2.09],2.798450042633953e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,22375,115,1.31 [0.95-1.80],0.0951637677105294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,22835,117,1.02 [0.93-1.12],0.6438999295313526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,20004,99,1.08 [0.88-1.33],0.4709458488564173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,19298,99,0.64 [0.36-1.14],0.1302997091238286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,22462,118,1.33 [1.09-1.63],0.0059525724973485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,19568,96,0.75 [0.40-1.43],0.3845904179302134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",20004,98,1.14 [0.85-1.52],0.3814820114451961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",19498,94,0.92 [0.71-1.19],0.5184811850830724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19980,101,1.02 [0.77-1.35],0.8787611732124141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,20004,98,0.95 [0.78-1.15],0.5811920126244992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,19384,97,0.93 [0.59-1.48],0.7729380204584233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,19298,99,1.09 [0.72-1.64],0.6919893976729256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,20004,99,0.98 [0.82-1.17],0.831623413744589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19384,97,0.92 [0.55-1.54],0.7600437511746116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,19498,94,1.13 [0.85-1.50],0.4020014531631124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,19498,94,1.19 [0.84-1.69],0.3294917423185439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,19440,96,0.99 [0.78-1.25],0.9199517961526756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19440,96,0.94 [0.59-1.48],0.781981781633299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,19980,101,0.62 [0.33-1.15],0.1267726383987457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,22462,118,0.95 [0.74-1.23],0.705495547658051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,22912,118,0.95 [0.66-1.35],0.7552474737122178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,19348,99,0.80 [0.50-1.29],0.3691132920020533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,19384,97,0.92 [0.60-1.43],0.7229847140945913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,19568,96,1.01 [0.82-1.25],0.927023204563728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,22998,120,1.63 [1.22-2.18],0.0008724680391435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,22367,117,0.95 [0.68-1.31],0.7485726849165584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,19384,97,0.92 [0.62-1.36],0.6722637909035111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,19440,96,0.92 [0.77-1.09],0.3142690388981047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22655,117,0.90 [0.68-1.19],0.4587238204769787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,19897,101,0.94 [0.65-1.35],0.719160717795398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,22927,121,1.36 [1.07-1.73],0.0129427686195064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,19396,99,1.08 [0.77-1.53],0.6480833536454816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,19460,94,0.90 [0.62-1.29],0.5506384939634972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19568,96,3.97 [1.58-9.97],0.0033953457360316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,22367,117,1.33 [1.06-1.68],0.0156562907588756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,19864,99,0.93 [0.57-1.50],0.7528668090862195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,19967,101,0.42 [0.20-0.84],0.0152830302832393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19980,101,0.79 [0.53-1.19],0.2601363742144863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22985,119,2.46 [1.36-4.43],0.0028164282698814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,22462,118,1.28 [0.99-1.65],0.0577286535839576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,22980,119,0.72 [0.40-1.31],0.2826161645467606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,22912,118,0.85 [0.46-1.60],0.6252813925415135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,23124,119,0.77 [0.50-1.20],0.2493468913376826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,22842,121,1.27 [1.08-1.50],0.0047050835488631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,23024,120,0.97 [0.83-1.14],0.7318580327110806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,22462,118,1.18 [0.90-1.55],0.2205804309750215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,22835,121,1.77 [1.14-2.76],0.010902710472546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19900,99,2.24 [1.34-3.74],0.0021429835195404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,23120,121,3.53 [2.03-6.13],7.297976323050447e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,22375,115,1.12 [0.91-1.36],0.2873417385160256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19897,101,1.10 [0.86-1.43],0.4459017030930309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19403,99,1.01 [0.58-1.77],0.9740381800503352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19900,99,0.84 [0.67-1.06],0.1366629692264385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22367,117,1.08 [0.89-1.30],0.4548370504959655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,19384,97,0.81 [0.44-1.48],0.4985265572588963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,19384,97,0.85 [0.62-1.18],0.3306630413370276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,19439,99,1.04 [0.56-1.95],0.8977466947752221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,22890,121,3.16 [2.00-4.99],7.561665791914923e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,22985,119,2.11 [1.39-3.20],0.0004485836991596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19439,99,0.85 [0.57-1.27],0.4381859382052497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,19439,99,1.07 [0.59-1.92],0.8309680396183021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,22300,115,1.63 [1.13-2.34],0.0088028012358423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,19612,99,0.78 [0.56-1.08],0.1353148548477708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,22985,119,0.44 [0.31-0.65],2.5002057542203253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,23024,120,1.25 [0.71-2.18],0.4445727796055105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,19897,101,1.03 [0.86-1.24],0.7579638847710838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,19980,101,0.84 [0.33-2.09],0.7014924574992855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,20025,100,0.91 [0.68-1.22],0.5429252242937548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,23141,119,2.85 [1.64-4.95],0.0001938296881048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,19439,99,1.03 [0.82-1.28],0.8191424029488293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22868,121,0.95 [0.80-1.13],0.5957359141925516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22462,118,1.56 [1.26-1.93],5.0821639043883e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,19498,94,0.84 [0.64-1.12],0.2402207653701412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,19980,101,1.54 [1.22-1.95],0.0002964084692026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19384,97,1.01 [0.76-1.33],0.9655640651122214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19612,99,1.14 [0.88-1.48],0.3098070700521095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,22367,117,1.01 [0.71-1.43],0.9545401419026862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19900,99,0.97 [0.80-1.18],0.7790491900567842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,19384,97,0.81 [0.59-1.12],0.2017538452837235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,19384,97,1.08 [0.68-1.72],0.738081399318258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,22775,117,2.40 [0.73-7.93],0.1506377427062534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,20004,98,0.89 [0.45-1.76],0.7368768059913741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,19967,101,1.31 [0.55-3.13],0.5482566574440385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,19104,94,2.95 [1.54-5.62],0.0010560896481238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,22904,119,1.42 [0.95-2.11],0.0872912139823312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,22912,118,1.01 [0.81-1.25],0.9642030656090952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,22367,117,1.36 [1.08-1.71],0.0086763939927021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,19498,94,0.71 [0.48-1.05],0.0883948468788031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,19934,98,0.90 [0.69-1.17],0.431239784866391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,19440,96,0.84 [0.60-1.18],0.3253018555875504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,19348,99,0.88 [0.57-1.37],0.5734612934119889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,19439,99,0.65 [0.25-1.66],0.3679653024674399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,22958,120,1.33 [0.70-2.50],0.3811868748231093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,19828,101,1.01 [0.77-1.33],0.9213866326918888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22775,117,1.20 [0.99-1.46],0.0653262164986392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,19298,99,0.97 [0.64-1.49],0.8981564673607042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19980,101,1.15 [0.88-1.52],0.3082297752571655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,22912,118,2.76 [1.51-5.08],0.0010356415068883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,19384,97,0.94 [0.78-1.14],0.5588788053213591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",22375,115,1.30 [0.94-1.80],0.1174412177145281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",19384,97,1.59 [1.05-2.39],0.0272213518258249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",22375,115,1.45 [1.13-1.86],0.0031418128864044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,23189,120,1.07 [0.38-3.03],0.8973848456194806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,20004,99,1.40 [0.59-3.33],0.4502672771821735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,23189,120,0.98 [0.63-1.54],0.9419143513195234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,19669,98,2.49 [1.67-3.71],7.899210864788972e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,22927,121,2.50 [1.71-3.66],2.4627543997753856e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,19439,99,1.04 [0.61-1.78],0.8861208512146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,19439,99,0.99 [0.82-1.19],0.882005376570188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,20004,98,1.69 [1.12-2.55],0.0121222130641189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,22478,115,1.33 [1.15-1.53],7.770462812204812e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,22868,121,1.13 [0.78-1.65],0.5179815526659802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,19384,97,1.11 [0.66-1.87],0.6897819342651611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,22367,117,0.99 [0.81-1.21],0.9129518879849996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,22912,118,1.63 [1.11-2.39],0.0123723678585426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,20004,99,2.16 [1.22-3.82],0.0084916827848035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,22927,121,0.61 [0.37-1.01],0.0542911790409761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,23120,121,1.09 [0.85-1.38],0.5112201036136648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,22927,121,0.85 [0.47-1.54],0.6012505590029553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,20025,100,0.89 [0.72-1.10],0.2805417952815382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,19980,101,0.86 [0.46-1.60],0.6362828463710664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,23020,119,1.41 [0.80-2.48],0.237755664207997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,22912,118,1.27 [0.74-2.19],0.383720058197055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,22462,118,1.18 [0.87-1.59],0.284738890709487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,19440,96,0.91 [0.49-1.67],0.7597625756795263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,23124,119,0.94 [0.73-1.21],0.632508671723861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20004,98,0.86 [0.67-1.11],0.2439203026991336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,19967,101,2.25 [1.57-3.22],8.810688950245739e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,22840,121,0.89 [0.74-1.07],0.2097029368780019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,22985,119,1.69 [1.34-2.14],1.189328334559053e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,22868,121,0.71 [0.44-1.15],0.1632592521877259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,22367,117,0.87 [0.54-1.40],0.5612301406362158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,22927,121,0.66 [0.35-1.24],0.192478114041475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,23124,119,0.48 [0.23-0.99],0.0483659999555642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22927,121,1.46 [1.26-1.70],4.02820465086657e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,22868,121,1.00 [0.82-1.22],0.9733063426829496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19897,101,1.01 [0.82-1.26],0.8946356803919912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,23084,120,1.31 [0.85-2.00],0.217112660389959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,23141,119,1.06 [0.81-1.38],0.6707816251030213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19498,94,1.34 [0.67-2.70],0.4085004650120891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19384,97,1.13 [0.83-1.54],0.4418378825626793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,19862,99,0.98 [0.78-1.22],0.8564804433422293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22835,117,0.85 [0.62-1.15],0.290884990124673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,22912,118,1.09 [0.80-1.50],0.57657122601417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,19439,99,0.88 [0.69-1.11],0.2731852965409261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,19384,97,1.14 [0.65-2.01],0.6383935912927287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,19384,97,0.71 [0.36-1.40],0.3273477278982242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,22375,115,0.96 [0.61-1.51],0.8574781251333343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,19439,99,0.77 [0.41-1.45],0.4177204434335608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,22699,117,1.05 [0.82-1.35],0.6777972493693524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,19980,101,2.89 [2.10-3.99],9.373086002830179e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,22339,114,0.64 [0.45-0.92],0.0159740062506221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,19612,99,1.00 [0.76-1.33],0.982232694820447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,19900,99,0.96 [0.72-1.27],0.7808176896708724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,22835,117,1.12 [0.68-1.85],0.6523941265343176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,22912,118,1.80 [1.22-2.64],0.0028015580354336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19612,99,0.66 [0.43-1.01],0.0570895942240221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,18834,92,1.00 [0.85-1.17],0.958199869719159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,22708,119,1.31 [1.03-1.67],0.0289530939676386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,23024,120,1.01 [0.71-1.43],0.9757471686001384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,22835,117,0.77 [0.60-1.00],0.0470557177707737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,19348,99,1.27 [0.89-1.80],0.1857913312034789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,19967,101,0.94 [0.78-1.14],0.5362050723386976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,19498,94,0.96 [0.71-1.29],0.7812821979473001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,22835,117,1.21 [0.84-1.76],0.3053383539477182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,19970,98,1.52 [0.58-3.98],0.3934810243839021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,19967,101,1.06 [0.68-1.64],0.7956365181501397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22958,120,2.18 [1.33-3.57],0.0021102667900201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,22760,119,1.36 [1.10-1.69],0.005505310293406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,23020,119,2.81 [1.35-5.86],0.0057746224359407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,19440,96,0.82 [0.48-1.38],0.4472199122557746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,19348,99,1.00 [0.69-1.45],0.9986689521291994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,19900,99,0.81 [0.57-1.14],0.2209943940167312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,19980,101,0.93 [0.69-1.26],0.6534376304312661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19498,94,1.00 [0.75-1.34],0.9968830707518328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,23124,119,1.13 [1.00-1.27],0.0412337695119657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,22797,116,1.36 [0.88-2.08],0.1629102061355682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,19384,97,0.79 [0.56-1.11],0.1760431902994528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,22462,118,1.03 [0.77-1.39],0.839539455228813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,22339,114,1.24 [1.03-1.50],0.0235830874140728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,22775,117,0.93 [0.82-1.05],0.2375496324963973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19980,101,0.93 [0.76-1.14],0.4732223913554272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19612,99,0.81 [0.53-1.23],0.3232718966774174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22478,115,1.23 [0.92-1.62],0.1575956380954113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,19498,94,0.64 [0.39-1.06],0.0861019454890679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19260,99,0.94 [0.63-1.40],0.7724322723518506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,22375,115,1.19 [0.91-1.56],0.1983305910306616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,19439,99,0.76 [0.43-1.35],0.3492132906712456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,19791,99,1.99 [1.11-3.54],0.0201395476826496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,19967,101,3.01 [2.12-4.26],6.582380582087478e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,19384,97,0.96 [0.71-1.29],0.7781007615436866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,23060,120,1.31 [0.73-2.35],0.3690208101908575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,22912,118,1.13 [0.63-2.02],0.6868492656980892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,22462,118,1.16 [0.82-1.65],0.3912431927720982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,19612,99,0.79 [0.58-1.07],0.1277831473548143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,22912,118,0.93 [0.68-1.27],0.6298962624439838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,22868,121,1.16 [0.89-1.51],0.275372684395368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,19568,96,1.14 [0.74-1.76],0.5569025433317625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,19298,99,1.16 [0.61-2.20],0.6445388301085009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,22375,115,1.17 [0.84-1.61],0.3545167115080183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19900,99,0.66 [0.32-1.37],0.2659313087432308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,19348,99,0.88 [0.68-1.15],0.3513995373721534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19529,96,1.79 [1.26-2.56],0.0012875061758979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,19980,101,0.94 [0.72-1.24],0.6614150318344243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,23071,118,1.97 [1.06-3.68],0.0332972687838936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,19980,101,1.80 [1.02-3.19],0.0440968253618168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,22927,121,1.17 [0.74-1.85],0.5031144644585344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,19900,99,0.81 [0.44-1.46],0.4771688215980917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,19900,99,0.62 [0.36-1.06],0.0824483893080346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,19897,101,1.52 [1.00-2.31],0.0475608473292482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,19298,99,1.15 [0.90-1.47],0.2580149692757661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,19897,101,1.31 [0.90-1.88],0.1556840783958313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,23189,120,1.34 [0.90-2.01],0.1532774216575304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19900,99,1.06 [0.82-1.37],0.6575135244702235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,20004,98,0.89 [0.72-1.09],0.2560378414598484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,23085,121,1.38 [0.96-1.97],0.0789437265745557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,22835,117,1.67 [1.03-2.70],0.0365798939986189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,23124,119,1.10 [0.83-1.45],0.5107917631255607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,22927,121,1.17 [0.91-1.51],0.2171130351077788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,19298,99,1.09 [0.76-1.55],0.643099829678828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19298,99,0.94 [0.64-1.37],0.7412399187706511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19384,97,1.12 [0.84-1.49],0.4477422337899872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19568,96,0.88 [0.73-1.06],0.1850176078012189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,23189,120,0.96 [0.76-1.20],0.7133966080278917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,23024,120,0.97 [0.81-1.18],0.7941329956164361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,22367,117,1.51 [0.90-2.54],0.1160519465710442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,22927,121,2.08 [1.22-3.56],0.0074504537147989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,23189,120,0.88 [0.55-1.40],0.5928368662243533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,19298,99,1.25 [0.79-1.97],0.3383978497372242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,19568,96,0.94 [0.45-1.99],0.8786688544050749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,20004,99,0.87 [0.63-1.21],0.403891191546582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,19298,99,1.15 [0.85-1.55],0.3686842959017058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,19980,101,0.94 [0.80-1.11],0.4806946946792066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,23024,120,0.98 [0.86-1.12],0.7984180731053365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22367,117,1.11 [0.81-1.52],0.5199592699430835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,19440,96,1.13 [0.80-1.60],0.4956363496987485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19298,99,0.94 [0.67-1.33],0.7315342993564252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,19384,97,1.18 [0.88-1.58],0.2629353419515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19439,99,1.94 [1.41-2.66],4.147948701118853e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,23189,120,0.87 [0.41-1.81],0.7020685090258123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,22912,118,1.00 [0.75-1.33],0.9982982981482272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,22912,118,0.75 [0.43-1.32],0.320806415755545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19498,94,1.54 [0.83-2.86],0.1728501751626369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,19568,96,1.57 [0.89-2.76],0.1196833672065474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,20025,100,1.41 [0.67-2.99],0.36331775278206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,19439,99,0.99 [0.84-1.17],0.887507119387262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,19894,98,0.85 [0.69-1.04],0.109081913123341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,22375,115,0.94 [0.69-1.29],0.7226217006361771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,19298,99,0.61 [0.39-0.95],0.0301505184368319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,19440,96,0.97 [0.71-1.32],0.8507841680201675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22792,116,1.19 [0.96-1.48],0.1208281479873634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,20025,100,2.07 [1.58-2.72],1.5082013933989036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20004,98,0.92 [0.64-1.32],0.6533570773127235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,23141,119,1.97 [1.38-2.82],0.0001911400814097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,23074,120,1.44 [1.02-2.04],0.0386274175095718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19774,97,0.88 [0.47-1.65],0.6934066931140392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,19384,97,1.29 [1.00-1.65],0.0466729011503002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,19440,96,0.66 [0.42-1.03],0.0651416092685441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,19439,99,0.93 [0.74-1.18],0.5697767027577552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,19980,101,0.97 [0.81-1.15],0.6905236463810793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,19900,99,1.20 [0.84-1.70],0.3141341740275359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,19298,99,0.91 [0.72-1.15],0.4151289635130615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22775,117,3.02 [1.71-5.34],0.0001491950325892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19568,96,1.02 [0.64-1.64],0.9194625218363348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,20025,100,1.45 [0.67-3.11],0.3445144445730865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,22601,116,1.74 [1.37-2.20],4.470455807290978e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19980,101,0.90 [0.69-1.16],0.4041940101940461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,22621,117,3.03 [2.12-4.32],9.731330941171615e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22868,121,1.09 [0.84-1.43],0.5062186311245587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22912,118,2.47 [1.44-4.22],0.0009516541459705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19439,99,0.93 [0.64-1.34],0.6922725917635733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22912,118,1.91 [1.27-2.86],0.0017280855734292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,22927,121,1.47 [1.08-1.99],0.0129884850547184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19568,96,1.03 [0.76-1.39],0.8350292888451977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,19260,99,0.99 [0.78-1.26],0.9483986850635586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,20004,98,1.63 [0.79-3.39],0.1875170184281059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,19384,97,1.24 [0.91-1.68],0.1712835183444848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,22948,120,1.19 [0.94-1.51],0.1519073588316309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,19612,99,0.96 [0.74-1.23],0.72469442903356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,22775,117,1.14 [0.86-1.51],0.3675686172833766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,22985,119,3.69 [2.10-6.46],5.319476885244285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,23147,120,0.40 [0.29-0.56],9.572974909746321e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",22839,120,1.30 [1.01-1.66],0.0383808680069713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,23024,120,0.96 [0.80-1.16],0.6627896997411009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,22912,118,0.88 [0.52-1.47],0.6199415943863116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,23117,120,1.90 [1.37-2.63],0.0001239561517664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,22912,118,1.12 [0.66-1.90],0.6688973111740331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,22770,119,5.33 [3.27-8.69],1.9806977346056755e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",19967,101,0.91 [0.66-1.25],0.5721496734966531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19439,99,1.02 [0.68-1.53],0.9068484691093176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19967,101,0.91 [0.74-1.11],0.3417556332377715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19967,101,0.87 [0.65-1.16],0.3486835759981433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,19515,94,1.13 [0.46-2.77],0.7958829250363326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,22375,115,1.40 [0.92-2.14],0.1165053307722625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,22927,121,1.13 [0.78-1.64],0.5192820153543396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,22927,121,0.94 [0.74-1.20],0.6353124901397714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,19941,101,1.01 [0.73-1.40],0.953760940361868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,23099,120,0.82 [0.53-1.27],0.3779845197004193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,22367,117,1.07 [0.70-1.65],0.7486682477993493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,19967,101,1.18 [0.59-2.37],0.6401467527687634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,22868,121,1.01 [0.83-1.23],0.9391566066112708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,23080,120,2.67 [1.38-5.14],0.0034057708385782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,22851,121,0.83 [0.58-1.18],0.2938209995170506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22815,121,0.96 [0.88-1.05],0.4119320812542358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,19384,97,0.84 [0.61-1.15],0.2685324823041648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,19384,97,1.05 [0.75-1.47],0.7768335949579246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,19440,96,1.11 [0.76-1.64],0.5864862072214371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,22334,115,1.03 [0.88-1.21],0.686188701101768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,20025,100,0.56 [0.42-0.77],0.0002348351883916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19967,101,0.86 [0.66-1.10],0.2282957727478695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,22916,119,1.03 [0.97-1.09],0.4133004279980297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,19498,94,1.03 [0.71-1.48],0.8797585329516717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,19348,99,1.25 [0.81-1.93],0.3194332381504728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22462,118,0.93 [0.80-1.08],0.3543584785985174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,22835,117,1.80 [0.62-5.26],0.2823080547740162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,22985,119,1.18 [0.66-2.10],0.5837557385295028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,19439,99,1.38 [0.95-2.01],0.089516625529217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19439,99,0.53 [0.25-1.13],0.0980195620867513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22835,117,2.09 [1.54-2.85],2.784359850318451e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,19498,94,0.66 [0.49-0.89],0.0057616504976425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,20025,100,0.64 [0.33-1.24],0.1901849907051039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,22478,115,2.23 [1.40-3.55],0.0007118205875736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,23024,120,0.70 [0.46-1.06],0.092076842161781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,20004,99,1.61 [0.98-2.62],0.0581498190819978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,19890,98,0.83 [0.66-1.05],0.123336927734159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,23124,119,1.08 [0.76-1.52],0.6796096225389856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,22916,119,1.00 [0.84-1.19],0.9836963322823852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,19612,99,0.94 [0.69-1.28],0.6903194976526379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20004,99,1.03 [0.75-1.41],0.8429751237470777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,19439,99,2.15 [1.47-3.16],8.471265018874881e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,22367,117,0.81 [0.46-1.44],0.473424459051776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,19439,99,1.08 [0.79-1.47],0.6465523780335136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,20004,98,0.78 [0.53-1.14],0.2002506859656502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,22835,117,1.01 [0.77-1.33],0.9333115538886656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19897,101,0.85 [0.67-1.08],0.17530304480247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22985,119,0.96 [0.81-1.15],0.6718263268963268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19612,99,0.87 [0.65-1.17],0.3482867509905961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19980,101,0.83 [0.64-1.07],0.1498733407975556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19980,101,1.66 [1.09-2.52],0.0174811334848872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,22927,121,0.98 [0.79-1.20],0.8228313522227111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,23141,119,0.96 [0.81-1.15],0.6569541708559067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19900,99,0.92 [0.78-1.09],0.3530674066361133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,22775,117,0.97 [0.65-1.44],0.871328451858328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,19440,96,1.08 [0.85-1.37],0.5460373481240359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,22902,118,0.88 [0.75-1.04],0.1402141425594087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,22367,117,1.14 [0.87-1.50],0.3293334797520404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,19298,99,0.72 [0.32-1.60],0.4182539956957899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,20004,99,2.90 [1.79-4.69],1.4671880010933055e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,19897,101,0.76 [0.43-1.34],0.3392457718163029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,23042,120,2.27 [1.48-3.46],0.0001553940377158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,22310,115,0.87 [0.71-1.06],0.1653686977923487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,19689,98,0.98 [0.71-1.33],0.8744114636811087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22462,118,1.16 [0.92-1.45],0.2065132283857194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",23141,119,1.01 [0.80-1.28],0.9491965716046742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,23120,121,0.74 [0.56-0.98],0.0369146948200321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,22462,118,1.39 [0.86-2.27],0.1829766195054224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,22916,119,0.96 [0.46-2.01],0.9219156840979263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,20004,99,1.49 [1.06-2.10],0.0232954140383934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,20004,99,1.13 [0.76-1.67],0.5490015039746552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22462,118,1.02 [0.75-1.39],0.9017281922357678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19440,96,0.95 [0.49-1.84],0.8678273485942303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22927,121,0.91 [0.75-1.10],0.320050449506415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19934,101,1.01 [0.80-1.28],0.939674665878228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,22462,118,1.01 [0.70-1.45],0.97276580091148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,19384,97,0.66 [0.39-1.12],0.1276362608775227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,19568,96,0.94 [0.80-1.10],0.462780356570781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22367,117,1.03 [0.80-1.33],0.8187478746727157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,23124,119,1.03 [0.84-1.27],0.7610809756972725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,19967,101,1.75 [1.28-2.38],0.000435539425042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,22942,119,1.13 [0.60-2.15],0.7023848261105735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,19384,97,0.82 [0.44-1.56],0.5501045836271533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,22868,121,1.06 [0.85-1.32],0.6167400711725544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,20043,98,0.61 [0.27-1.39],0.2412926415284177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,19432,96,1.30 [0.99-1.70],0.0571550103474644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,19439,99,0.74 [0.45-1.20],0.2203190852347402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,19498,94,1.75 [1.08-2.83],0.0219958457294101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,22980,119,1.06 [0.77-1.44],0.7287870114149984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,19439,99,1.79 [1.30-2.48],0.0003784240665017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,22855,121,1.14 [0.76-1.70],0.521911775649109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,19967,101,1.17 [0.71-1.94],0.541998586829946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,22835,120,2.34 [1.66-3.30],1.3650249305959612e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22375,115,0.95 [0.82-1.11],0.5226552548097703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,23120,121,1.56 [0.83-2.94],0.1667264114074117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,22298,117,1.30 [0.95-1.78],0.1045272441316877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,19612,99,1.96 [1.30-2.95],0.0013044221727142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,19811,98,2.15 [1.34-3.43],0.0013831490315106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,19900,99,1.35 [0.94-1.95],0.1065600804127959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,19900,99,1.04 [0.96-1.12],0.3343796849510506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22775,117,1.17 [0.99-1.37],0.0587555650190457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,22868,121,1.20 [0.95-1.51],0.117670061193315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,22367,117,1.19 [0.85-1.66],0.3166311231316913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,19298,99,1.08 [0.57-2.07],0.8088447439827657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19980,101,0.81 [0.54-1.23],0.3241616913239605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19440,96,0.91 [0.62-1.34],0.6293482760342873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22835,117,1.07 [0.80-1.42],0.6618681331988592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,22742,117,1.14 [0.74-1.77],0.5567295067908664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,22664,115,1.44 [0.92-2.24],0.1085473546393814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,22868,121,1.14 [0.84-1.56],0.4001387307411308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,19439,99,0.97 [0.69-1.36],0.8471333655556272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,22868,121,0.97 [0.82-1.14],0.6806005477253312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,22367,117,1.09 [0.83-1.43],0.549417961480001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18833,94,0.93 [0.77-1.12],0.4271554069326696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22375,115,1.38 [0.79-2.40],0.2520565821966287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,22719,119,1.82 [1.11-2.96],0.0168317294671976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,19273,99,0.92 [0.64-1.33],0.655071303713473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,20004,98,1.30 [1.03-1.64],0.0243566661901842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,19440,96,1.32 [1.06-1.66],0.0149671463604293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22868,121,1.25 [0.87-1.80],0.2255177737971614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,22375,115,1.55 [1.08-2.23],0.0184074516929947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,22478,115,1.63 [1.20-2.23],0.0019145736136937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,19439,99,1.08 [0.77-1.52],0.6403002414650538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22775,117,1.02 [0.82-1.26],0.8581859877523659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22984,120,0.97 [0.80-1.16],0.7065368998773076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19402,99,1.19 [0.73-1.95],0.4781311969024113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,20004,98,2.11 [1.18-3.79],0.0120655705304034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,20004,99,1.24 [0.54-2.82],0.6147983164843609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,23189,120,0.64 [0.37-1.12],0.1186447530164289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,19900,99,1.10 [0.74-1.65],0.6433795495634246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19900,99,1.04 [0.44-2.44],0.9298297907948428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22832,121,0.99 [0.51-1.93],0.9863972305775937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22691,117,1.76 [1.14-2.74],0.0113434915218185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,19967,101,1.07 [0.65-1.76],0.7989745591339805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,23189,120,0.47 [0.24-0.90],0.0229739281709096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20004,98,2.07 [1.18-3.63],0.0113005220889296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19568,96,0.71 [0.50-0.99],0.0422540895508931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,22283,114,1.36 [1.05-1.78],0.0207526977460834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,19612,99,1.02 [0.69-1.51],0.9271999959423652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,22868,121,1.69 [1.16-2.47],0.0061050211380061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,23010,120,0.90 [0.78-1.03],0.1271972158429467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,23124,119,2.16 [1.50-3.10],3.288847460743352e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,19897,101,1.01 [0.73-1.41],0.9340985418279732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,22375,115,1.57 [1.23-2.01],0.0003218360720624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,19498,94,1.37 [0.94-1.99],0.1012600180712724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,19384,97,1.30 [1.07-1.57],0.0077291324615244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,20043,98,0.98 [0.73-1.32],0.893762043786398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,22827,120,1.03 [0.70-1.50],0.8929935698812422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,22940,120,1.50 [0.82-2.74],0.1908698856790714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,19627,97,1.17 [0.79-1.73],0.426000874850484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,20004,98,1.10 [0.77-1.57],0.5904819439181648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,20004,98,0.92 [0.77-1.11],0.3862014288661352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,20004,98,0.89 [0.70-1.12],0.3205362775433289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,19897,101,0.93 [0.68-1.28],0.6646725100849655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,19384,97,0.87 [0.64-1.18],0.359866684254932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,22462,118,0.96 [0.78-1.18],0.7159149790019833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,19384,97,1.01 [0.82-1.24],0.9581533767003366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19348,99,0.77 [0.51-1.17],0.2228687641728217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,19897,101,1.19 [0.84-1.70],0.3338544854061406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,22868,121,0.53 [0.37-0.76],0.0004488117252332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,22375,115,1.16 [0.83-1.62],0.3746964790823028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,19568,96,0.86 [0.66-1.13],0.2791001443676928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,22367,117,1.11 [0.85-1.43],0.4464170177425666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,22462,118,1.08 [0.82-1.42],0.594440564385162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,19440,96,0.83 [0.59-1.17],0.2911974371624048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,22367,117,1.01 [0.70-1.46],0.9502069236443548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,19612,99,0.68 [0.42-1.09],0.1086622789361793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,19439,99,1.37 [0.70-2.66],0.355735948689299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,19897,101,1.48 [1.12-1.96],0.0065106772730972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,19498,94,0.88 [0.60-1.30],0.5222323720394793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,19348,99,0.81 [0.44-1.51],0.5151682582057092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,22367,117,1.18 [0.87-1.59],0.2871354149162206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,19439,99,0.93 [0.67-1.30],0.6685673329175602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,19612,99,0.91 [0.62-1.33],0.623340790881477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,22367,117,0.91 [0.54-1.55],0.7395286180162283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,23020,119,1.56 [1.15-2.11],0.0041190766178135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,22375,115,1.02 [0.61-1.72],0.9394480833647266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19298,99,0.80 [0.52-1.24],0.3208261077321629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,22367,117,1.29 [1.02-1.62],0.0318950412334732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,19980,101,2.36 [1.71-3.25],1.3470698534642664e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,22380,115,1.30 [0.95-1.78],0.1040373590285395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,19980,101,0.81 [0.62-1.06],0.1241646784912392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,19384,97,0.58 [0.34-1.00],0.0514920094235745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,19298,99,0.73 [0.46-1.17],0.1874533263737638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,19440,96,1.10 [0.83-1.44],0.5123655161063799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,22835,117,1.37 [1.12-1.68],0.0024141915092183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,22835,117,1.63 [1.28-2.08],7.33291550172433e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,19900,99,1.27 [0.96-1.68],0.0913870016405396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,19439,99,0.91 [0.65-1.29],0.5968555043482862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,19498,94,0.94 [0.77-1.15],0.5694595948516833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,19897,101,1.34 [1.00-1.79],0.0508462332172802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,22478,115,1.37 [1.06-1.77],0.0155371570623939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19498,94,0.94 [0.35-2.54],0.9013782203580148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,19980,101,0.93 [0.68-1.27],0.6400532679973896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,22760,119,1.66 [1.25-2.19],0.0004120762355357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,23189,120,1.46 [1.14-1.88],0.0028291921912804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,23189,120,1.61 [1.28-2.03],6.047680142502401e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,19897,101,0.92 [0.56-1.50],0.7281267593271262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,22958,120,1.28 [0.93-1.77],0.1362783309314383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,19439,99,1.13 [0.80-1.59],0.4827328485826073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,22912,118,3.27 [1.98-5.39],3.572273523664688e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,22927,121,1.66 [1.38-2.00],7.875686031288136e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,19439,99,0.99 [0.60-1.63],0.9608084054140142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,19298,99,1.41 [0.89-2.22],0.1429823726555129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22835,117,0.89 [0.60-1.33],0.5660564570343601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,22847,118,1.20 [0.82-1.73],0.3450500395155149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",19384,97,0.91 [0.60-1.38],0.6500178394071765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,19897,101,0.64 [0.24-1.68],0.3619416760471234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,19980,101,0.90 [0.70-1.16],0.4197633093847743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19612,99,1.13 [0.86-1.48],0.3874710287125714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,23124,119,0.52 [0.31-0.88],0.0145752906071718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,23124,119,1.41 [0.75-2.64],0.2808220023475487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,19980,101,0.85 [0.61-1.19],0.3461231762080351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,22462,118,0.88 [0.67-1.16],0.3587144986327477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,22625,117,0.94 [0.82-1.08],0.3847336129407465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,19439,99,0.97 [0.64-1.45],0.8693596899002989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19568,96,1.62 [1.14-2.31],0.0071904980841898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,23050,120,0.99 [0.75-1.29],0.9208015074905808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,20004,98,0.92 [0.76-1.13],0.446153351576277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19384,97,0.95 [0.70-1.27],0.709967736993182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,19980,101,0.87 [0.68-1.11],0.256964690241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,19534,96,0.94 [0.82-1.08],0.3953881668854379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,20025,100,2.27 [1.25-4.13],0.0074409161343262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,19498,94,1.64 [1.22-2.21],0.0010365133590944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,22825,121,1.02 [0.88-1.18],0.7883075370747348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,19371,97,2.02 [1.06-3.85],0.032103474365835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,19879,100,2.65 [1.83-3.85],2.663765501526024e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,19980,101,0.57 [0.34-0.96],0.0350396903627553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,23076,120,2.73 [1.66-4.48],7.32894700938515e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,19498,94,3.43 [2.00-5.91],8.270029140229787e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,19439,99,1.01 [0.61-1.67],0.9676364823543776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,19439,99,0.79 [0.42-1.47],0.4500763705004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,19612,99,0.98 [0.72-1.32],0.8876792634558386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,22367,117,1.14 [0.89-1.46],0.2933591620152724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,19612,99,1.14 [0.86-1.50],0.3513388067317146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,19498,94,0.86 [0.66-1.12],0.2573831971428618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,22958,120,1.78 [0.94-3.36],0.0760548186596869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,23124,119,1.24 [0.63-2.44],0.5403241037005078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,19498,94,1.44 [0.47-4.43],0.5278776616031231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22927,121,1.23 [0.74-2.05],0.4270739943166438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,22835,117,1.25 [0.86-1.83],0.2476200999608753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,19439,99,0.89 [0.45-1.75],0.7402689332548174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,19612,99,0.92 [0.68-1.24],0.582029109069438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,19440,96,1.03 [0.65-1.64],0.8909328214154167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,19498,94,1.36 [0.92-2.02],0.1242206298592384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,19384,97,0.80 [0.46-1.38],0.417628239749225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,19440,96,0.96 [0.82-1.13],0.6467845473363483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22367,117,1.38 [1.11-1.70],0.0031031611488803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22367,117,0.82 [0.64-1.06],0.1238029315207296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,19348,99,0.93 [0.76-1.15],0.5135419441848024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,22775,117,1.20 [0.76-1.88],0.4356747499194857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,23120,121,1.65 [0.97-2.80],0.0642201574909352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,22835,117,1.59 [1.04-2.41],0.0312945785624969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,19384,97,1.04 [0.72-1.49],0.8490818629507035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19980,101,0.93 [0.75-1.16],0.5232211587776081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,23120,121,0.84 [0.52-1.35],0.4687479088395614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,22367,117,1.09 [0.94-1.26],0.2463293075936365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,23124,119,0.91 [0.70-1.18],0.4608801894942508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,19384,97,1.01 [0.56-1.83],0.9695055265281792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,22744,120,1.36 [1.03-1.79],0.0284253421966364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,22620,114,1.30 [1.05-1.60],0.0151142505171613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,19439,99,0.84 [0.47-1.48],0.5410474616916015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,19980,101,0.83 [0.57-1.22],0.3507026762414059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,22339,114,1.21 [0.96-1.54],0.1104917223212868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,19897,101,0.91 [0.57-1.45],0.6950084703604179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,22985,119,0.91 [0.68-1.21],0.5206637305735278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,19980,101,1.34 [0.91-1.98],0.14187485437144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,22478,115,1.34 [1.04-1.73],0.0250620549302749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,20043,98,0.61 [0.22-1.68],0.3375406121106471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,19980,101,0.75 [0.34-1.62],0.4606471286941009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,19348,99,0.84 [0.56-1.27],0.4144446157958729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22868,121,1.08 [0.86-1.36],0.4823759337575243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,19612,99,1.08 [0.84-1.39],0.5429886721286221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,19921,98,0.90 [0.75-1.08],0.2539121606027646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19384,97,1.18 [0.73-1.89],0.5024369390355621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,19384,97,0.80 [0.52-1.24],0.3222188254247846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,19612,99,1.15 [0.89-1.48],0.2778741276377042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,19980,101,0.82 [0.40-1.67],0.5805162605155991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,19966,99,1.55 [0.89-2.69],0.1182674594813829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,22835,117,1.02 [0.84-1.24],0.8650420191937959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,23124,119,2.15 [1.26-3.69],0.0052860320011555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,22375,115,0.82 [0.58-1.16],0.2555392396792064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,22351,115,2.95 [1.92-4.52],7.292980293299039e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,23189,120,1.07 [0.73-1.57],0.7390160587799139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,23124,119,2.09 [1.20-3.65],0.0092654429016817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,23014,119,1.93 [1.17-3.16],0.0095553848296074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,22958,120,1.24 [0.76-2.02],0.3804680122482258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,22952,120,0.57 [0.45-0.72],1.999700225501324e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,19384,97,1.56 [1.02-2.39],0.0386145283466094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,19568,96,3.56 [1.69-7.50],0.0008545481771512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,22984,120,1.11 [0.94-1.30],0.2181602053983827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,22462,118,1.30 [0.91-1.83],0.1445219699016858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,19348,99,0.88 [0.66-1.17],0.3866998115429503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,23050,120,2.08 [1.58-2.75],2.0330975497976202e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,19348,99,0.69 [0.43-1.12],0.1354374055372606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,19440,96,1.53 [0.89-2.62],0.1255936293409301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,19440,96,0.64 [0.33-1.22],0.1708860129878061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,19348,99,0.77 [0.48-1.24],0.2878391915935107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,19498,94,1.67 [1.08-2.57],0.0200709159652968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,22367,117,1.07 [0.88-1.32],0.4906339283925431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,19418,94,1.52 [1.04-2.22],0.0304450013254687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,20004,98,1.91 [1.04-3.52],0.0366163461359749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,19498,94,1.11 [0.92-1.34],0.2721027346686544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,22868,121,0.87 [0.65-1.18],0.3801402742583443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,19440,96,0.74 [0.48-1.16],0.1954424027525483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,22927,121,1.33 [0.92-1.93],0.1271803390181399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,22927,121,0.57 [0.40-0.80],0.001175991593128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,19897,101,0.96 [0.81-1.14],0.664697847002464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,19900,99,1.37 [1.10-1.71],0.0050355178568989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,19568,96,0.61 [0.35-1.07],0.0876800571332892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,19498,94,0.90 [0.69-1.17],0.4207648226017108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,19498,94,1.46 [0.90-2.37],0.1211005219054538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,23189,120,1.64 [1.17-2.29],0.003954228896741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,20043,98,0.24 [0.10-0.58],0.0015522670869784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,20043,98,0.61 [0.27-1.40],0.246333894605058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,22980,119,0.94 [0.71-1.26],0.6898639229665138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,22868,121,1.17 [0.66-2.10],0.5873094031463821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,22927,121,2.01 [1.09-3.71],0.0254938962007109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,19568,96,0.96 [0.62-1.51],0.8733653341329465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,22835,117,1.03 [0.57-1.89],0.915399565471106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,23124,119,0.89 [0.51-1.55],0.6772329489136749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,19439,99,1.04 [0.47-2.28],0.9216124080783084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,23117,120,1.34 [0.77-2.35],0.2996412261054124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,19980,101,1.08 [0.83-1.40],0.5607263616298643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,19612,99,1.09 [0.78-1.53],0.6074033113115924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,19930,101,2.29 [1.48-3.55],0.0002005567639133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,22835,117,1.37 [0.79-2.39],0.2612347872890546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,19655,96,5.60 [0.57-55.22],0.1400645778341586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,23189,120,1.89 [1.24-2.85],0.0027463154991966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,22260,120,0.97 [0.83-1.12],0.6601614441877421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,19961,98,2.45 [0.78-7.67],0.1248292005435627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,19671,95,0.62 [0.27-1.39],0.2457733859916214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,19748,97,0.75 [0.39-1.44],0.3875639811893278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,20043,98,2.17 [0.84-5.57],0.1075117524855724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,20043,98,1.03 [0.37-2.88],0.9535344799012092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,22720,114,1.22 [0.98-1.52],0.0744796425519901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,22843,118,1.04 [0.86-1.25],0.7154199748803147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,22478,115,1.06 [0.75-1.51],0.7257075865012712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,23054,119,1.02 [0.78-1.35],0.8674554244292049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,23141,119,1.49 [1.21-1.83],0.0001578779863777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,22775,117,1.14 [0.68-1.91],0.6156199707842316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,19996,98,0.48 [0.13-1.77],0.2716355788094245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,19996,98,1.45 [0.72-2.91],0.2982484552234162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,23189,120,1.10 [0.86-1.40],0.4572345755653493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,20004,98,1.03 [0.76-1.38],0.869066677572774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,19737,96,1.45 [0.68-3.08],0.3401132074242037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,19658,96,0.34 [0.08-1.40],0.1365990107111117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,19996,98,3.57 [1.29-9.85],0.0141493058165896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,19612,99,1.02 [0.87-1.19],0.820886215264245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,19530,96,0.56 [0.29-1.12],0.1016024667587116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,19900,99,0.75 [0.52-1.08],0.1220197464270249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22375,115,1.01 [0.77-1.32],0.9392208602926674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,22705,117,1.52 [0.90-2.56],0.1169706639202807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,19440,96,1.62 [0.90-2.91],0.1083981858526418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,22985,119,1.07 [0.59-1.93],0.8259032978479504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,22835,117,2.28 [1.23-4.23],0.0091280252007201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,22835,117,0.87 [0.69-1.09],0.2238807676354864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,22701,117,1.62 [1.15-2.29],0.0064195341018748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,19568,96,0.49 [0.31-0.77],0.0020167490539004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,22367,117,1.04 [0.79-1.37],0.7703889898624223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,22367,117,1.52 [1.17-1.98],0.0016717007636449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,22927,121,1.21 [0.95-1.54],0.1219408696344764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,19662,97,1.13 [0.81-1.58],0.4804239368929532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,22367,117,0.95 [0.80-1.13],0.5803746573195177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,22868,121,0.99 [0.74-1.34],0.9605803560827738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19348,99,0.90 [0.63-1.28],0.5530103109947695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,19900,99,0.75 [0.46-1.22],0.2410798475151633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,19504,99,1.10 [0.87-1.40],0.4236503349089788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,19967,101,1.10 [0.82-1.46],0.5358969671717563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,20025,100,1.41 [0.98-2.03],0.0654010475929675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,19298,99,1.00 [0.84-1.19],0.996151636625175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,19341,97,1.10 [0.90-1.34],0.3639104353465674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,19439,99,0.76 [0.46-1.25],0.2741726154051168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,20004,99,3.01 [1.93-4.70],1.2191136185773222e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22984,120,1.05 [0.87-1.27],0.5906402080058333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,19612,99,0.94 [0.58-1.53],0.8026080605524303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,22947,117,1.29 [0.92-1.83],0.1427235435853578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,23024,120,2.37 [1.67-3.36],1.3189713152642089e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22868,121,2.11 [1.34-3.33],0.0013575812486174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22375,115,1.10 [0.92-1.31],0.306673266114197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22912,118,1.00 [0.87-1.16],0.9626577559761438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,23120,121,1.29 [0.83-2.00],0.2537467173998984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22927,121,3.68 [2.20-6.16],7.601642975653335e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19498,94,1.96 [1.28-2.99],0.0017975423535615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,23086,120,2.12 [1.22-3.69],0.0079505389374938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,19498,94,1.10 [0.63-1.92],0.7469590441939067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22957,120,1.30 [0.96-1.76],0.0860488109359693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,22880,119,1.69 [1.18-2.42],0.0040979671644474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19439,99,1.08 [0.87-1.36],0.4787743107215056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22835,117,0.97 [0.81-1.17],0.7769860865300187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22375,115,1.09 [0.82-1.44],0.5487495377040059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,22462,118,1.12 [0.85-1.49],0.4170007325590689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,22728,117,1.03 [0.83-1.29],0.7631850537641094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,23024,120,0.99 [0.85-1.16],0.8951344740703652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,19384,97,1.00 [0.65-1.53],0.9947632731576556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,19980,101,0.90 [0.75-1.09],0.2730932562692983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,22462,118,1.20 [0.91-1.60],0.203568098901394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,22367,117,1.46 [0.94-2.28],0.0919628122924286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,22868,121,1.13 [0.85-1.49],0.3979377042576306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,22367,117,2.02 [1.48-2.75],8.221503884112218e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,19384,97,1.13 [0.56-2.29],0.7280602862678798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,19897,101,1.05 [0.77-1.42],0.7739764901557259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,22375,115,1.24 [0.99-1.55],0.0563724810845126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,19440,96,0.94 [0.64-1.39],0.7640878146356582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,22375,115,1.00 [0.79-1.28],0.9874052387898884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,19298,99,1.38 [1.09-1.75],0.0079855762801165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,19298,99,0.69 [0.42-1.13],0.138099807263774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,22375,115,1.61 [1.07-2.43],0.0236577939675633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,22868,121,1.11 [0.85-1.46],0.4467573747966195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,19440,96,0.75 [0.51-1.09],0.1327760308947411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,20004,99,0.87 [0.59-1.30],0.5085122320889401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,19384,97,1.01 [0.78-1.31],0.9204090813855096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19568,96,0.93 [0.72-1.18],0.5389159020663358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19900,99,1.05 [0.73-1.52],0.7842861768320321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19298,99,0.78 [0.54-1.15],0.207988547383464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,22375,115,1.11 [0.81-1.53],0.4988324354186754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,19439,99,0.79 [0.43-1.46],0.4487049510076563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,23120,121,0.67 [0.44-1.02],0.063017499507438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,22478,115,0.76 [0.47-1.25],0.2871497183350392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,19612,99,0.75 [0.53-1.06],0.1039437016025752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,19900,99,1.00 [0.79-1.26],0.9935609863807467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,19850,98,1.20 [0.78-1.87],0.4079291440602799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,22367,117,0.93 [0.76-1.15],0.526369663618067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,19897,101,0.97 [0.73-1.28],0.8073488350295903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,19897,101,0.95 [0.64-1.41],0.802563438893196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,22835,117,1.67 [0.72-3.85],0.232494008662465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,22375,115,1.17 [0.95-1.45],0.1397962359153071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,19298,99,1.02 [0.75-1.40],0.8899341096596504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,19900,99,1.20 [0.92-1.56],0.1866496898482224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,23120,121,2.06 [1.29-3.29],0.0023118238545137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,23024,120,2.09 [1.45-3.03],9.064547361831106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,23012,119,1.69 [1.25-2.30],0.0007638548111065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,19439,99,1.22 [0.91-1.64],0.1885340964528199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22988,120,1.06 [0.82-1.37],0.6301812955770889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19897,101,1.16 [0.93-1.46],0.1849192001335575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,19348,99,0.84 [0.59-1.21],0.3497603797141949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,19927,101,1.10 [0.91-1.33],0.3309345273543969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,22927,121,0.98 [0.81-1.18],0.8148781618976573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,19348,99,1.23 [0.81-1.86],0.3359815009145473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,22985,119,0.97 [0.81-1.16],0.7195682819530584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,19980,101,1.05 [0.75-1.47],0.7819949165737212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,19568,96,0.89 [0.75-1.07],0.2191364393813712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,22775,117,1.12 [0.87-1.44],0.3759715458272489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19498,94,1.20 [0.68-2.13],0.5331128271441369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',19967,101,1.31 [0.97-1.77],0.0829398412283285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,19384,97,0.94 [0.67-1.31],0.7073763975417953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,19568,96,0.94 [0.65-1.37],0.7587673458114487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,19900,99,0.92 [0.59-1.43],0.7067006836779974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,19897,101,1.19 [0.94-1.50],0.1482153904503477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,19498,94,0.55 [0.26-1.18],0.1243711188402627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,22927,121,0.99 [0.78-1.26],0.9611397750367282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],22430,118,1.00 [0.71-1.41],0.9864025312381004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",22912,118,1.65 [1.15-2.39],0.0072408713957437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,20025,100,0.90 [0.63-1.28],0.5434367567326527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,19980,101,1.30 [0.92-1.82],0.132628498989935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,22367,117,1.94 [1.25-3.01],0.0029850829979964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,23014,120,1.07 [0.84-1.36],0.5697496311236943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,22890,121,1.02 [0.66-1.57],0.9413777226928652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,22890,121,0.60 [0.39-0.91],0.0167776368376941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19440,96,0.87 [0.58-1.31],0.497457554736009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,19944,101,0.81 [0.34-1.92],0.6309293865824033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,19440,96,0.98 [0.47-2.06],0.9676537867739352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19980,101,0.85 [0.42-1.72],0.6556929868437589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,19980,101,0.67 [0.45-1.00],0.0481416260693141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,22985,119,0.98 [0.78-1.24],0.8869786725174053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,22905,117,0.92 [0.50-1.68],0.7878055895134322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,19568,96,0.91 [0.69-1.18],0.4627261354688569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,20004,98,1.10 [0.54-2.24],0.7895721391613317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,22912,118,1.66 [1.22-2.26],0.0013253078312298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,19568,96,1.32 [0.80-2.17],0.2760330071838094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,22868,121,1.45 [1.15-1.82],0.0016512150142134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,22912,118,0.77 [0.46-1.28],0.3149373334749445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,23120,121,1.32 [0.98-1.79],0.070975218846196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,19384,97,0.69 [0.36-1.32],0.2647654870866912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,22846,118,2.09 [1.31-3.33],0.0019835996838429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,23024,120,1.58 [1.06-2.36],0.0238103253602449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,19900,99,0.93 [0.81-1.08],0.3566166644739463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,22775,117,0.52 [0.27-1.01],0.0550071609052532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,22958,120,2.32 [1.56-3.44],3.205818615462963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,22815,119,3.48 [2.33-5.19],1.0068598654172101e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,23146,120,1.52 [1.10-2.11],0.0122520653351044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19439,99,1.03 [0.66-1.61],0.9002812659840983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,19298,99,0.96 [0.65-1.41],0.8238728292993315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,19612,99,0.92 [0.70-1.19],0.5143298822969034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,19967,101,0.90 [0.68-1.20],0.4856517527483812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,22462,118,1.06 [0.88-1.26],0.5516420409500818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19348,99,0.62 [0.31-1.24],0.1772384606823882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,19967,101,1.08 [0.65-1.80],0.7565175916895771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,22944,118,0.92 [0.80-1.06],0.2490441694728435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,22835,117,1.34 [1.03-1.73],0.028420740595983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,22868,121,1.00 [0.82-1.23],0.9764912166746548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,20004,98,1.43 [0.78-2.59],0.2447299853265665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,22375,115,1.25 [0.98-1.59],0.0773516530932409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19439,99,0.98 [0.59-1.64],0.9475587647353908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22890,121,0.74 [0.63-0.88],0.0007657855690539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22980,119,1.30 [0.88-1.91],0.1820780359308866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,19298,99,0.83 [0.42-1.65],0.5966949573437748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19900,99,0.90 [0.61-1.33],0.5933080605949179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,19568,96,0.82 [0.57-1.17],0.2722035591629302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22835,117,1.42 [1.03-1.97],0.0339249380379718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23189,120,2.33 [1.38-3.93],0.0014804688128439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19439,99,1.11 [0.76-1.62],0.5823395649847379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,20004,99,1.19 [0.61-2.33],0.6116521060658182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,19897,101,0.76 [0.44-1.31],0.3270207155003843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,22728,117,0.90 [0.69-1.17],0.4260286099241629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,19439,99,0.93 [0.71-1.21],0.5780255247571862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,22835,117,0.93 [0.82-1.05],0.2272664876881789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19298,99,1.00 [0.73-1.36],0.9977902616322372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,23124,119,1.65 [1.14-2.38],0.0074926634735277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,22882,116,1.04 [0.57-1.92],0.8897695847518967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,19348,99,1.09 [0.86-1.38],0.4834250727316252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,22884,118,0.96 [0.74-1.24],0.7327422494271019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,22478,115,0.95 [0.75-1.20],0.6776680456519357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,22375,115,0.86 [0.65-1.14],0.3049875274600696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,22927,121,0.94 [0.77-1.13],0.4986203245559376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",19298,99,1.05 [0.86-1.29],0.6049531786828265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,22367,117,0.81 [0.59-1.11],0.1903789707087988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,19440,96,0.68 [0.39-1.20],0.1802795148078679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,19967,101,0.81 [0.46-1.43],0.4720388975211006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,22835,117,1.14 [0.90-1.43],0.2842908022517409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,19439,99,0.74 [0.43-1.26],0.2649256305946071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,22367,117,1.11 [0.88-1.41],0.3563749566285406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,19439,99,0.72 [0.48-1.07],0.1051587276749524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,22868,121,1.35 [1.00-1.82],0.0536470652106616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,19980,101,0.91 [0.71-1.17],0.4456702029677482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,22367,117,1.04 [0.70-1.54],0.8407579275795437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,19900,99,1.01 [0.63-1.64],0.9561627103678488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,22367,117,0.96 [0.78-1.18],0.668640654562123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,23124,119,0.98 [0.86-1.11],0.7503382893425797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,22868,121,1.50 [1.21-1.86],0.000182556230178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,19439,99,1.19 [0.95-1.49],0.1362752020269828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23124,119,0.90 [0.66-1.24],0.5339134638493375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",19980,101,1.36 [1.04-1.76],0.0225545070437133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,22478,115,0.87 [0.62-1.23],0.4362572239062772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,22912,118,1.70 [1.09-2.65],0.0185870712351517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,19897,101,1.28 [0.85-1.92],0.231951862171604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,19456,96,1.25 [0.71-2.21],0.4446723518740598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,19440,96,0.86 [0.61-1.21],0.3784830443711289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,19900,99,1.65 [1.14-2.38],0.0082716996257424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,19568,96,0.80 [0.55-1.16],0.232099268010204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19348,99,0.88 [0.61-1.27],0.490215867999173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,19967,101,1.47 [1.03-2.09],0.0329135001874145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,20004,98,0.97 [0.74-1.27],0.8132782598837092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19612,99,0.92 [0.77-1.11],0.4054630415437384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,22835,117,0.93 [0.81-1.08],0.3317041575554916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,20323,105,1.97 [1.19-3.25],0.0080645002446576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,19897,101,0.74 [0.44-1.24],0.2499035499346649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,22835,117,2.25 [1.52-3.33],5.308441937272663e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,19298,99,0.95 [0.68-1.33],0.7681485343115477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,19921,99,1.12 [0.73-1.72],0.611371419541122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,22462,118,1.06 [0.84-1.34],0.6167247800714646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,19612,99,1.03 [0.75-1.41],0.8700167220900776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,22375,115,1.01 [0.82-1.26],0.8945573531756951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19440,96,0.99 [0.76-1.29],0.9342221117296576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19897,101,0.84 [0.49-1.45],0.5389885935413472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,19967,101,0.98 [0.72-1.32],0.874848453999422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,22375,115,1.18 [0.84-1.65],0.340944464267191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,22835,117,0.90 [0.75-1.09],0.2862795385135923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,22868,121,1.10 [0.90-1.34],0.3403757318153945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,19568,96,0.86 [0.68-1.09],0.2259583689422992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,22775,117,0.99 [0.84-1.17],0.9358101790510992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,22775,117,0.98 [0.80-1.21],0.8777963329425988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22367,117,0.92 [0.75-1.12],0.4037947558516663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,19440,96,0.86 [0.54-1.36],0.5227867181201074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,22737,117,1.04 [0.87-1.24],0.643753536095909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,22478,115,0.92 [0.73-1.16],0.4652654806493732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,19614,99,1.82 [1.02-3.23],0.0410269838057259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,23146,120,1.87 [1.14-3.07],0.0127960526854312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,20004,98,1.93 [1.20-3.11],0.0069997643042732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,19612,99,1.05 [0.76-1.45],0.746728252151521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,20004,98,2.81 [1.47-5.39],0.0018122302816852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,22375,115,1.06 [0.94-1.19],0.3756239153169519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",19440,96,1.21 [0.80-1.84],0.3737791592526956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,19897,101,1.10 [0.84-1.44],0.5009497699309513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,22375,115,1.03 [0.84-1.25],0.8035781980524197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,19384,97,1.06 [0.68-1.65],0.8005664556476034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,22985,119,1.42 [0.68-3.00],0.3533678066781178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,19439,99,0.64 [0.31-1.34],0.2367040859725738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,19571,99,0.92 [0.74-1.15],0.4611699005666652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,19440,96,0.74 [0.44-1.24],0.255207591534151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,19612,99,1.12 [0.77-1.64],0.5507396128065802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,20043,98,1.01 [0.42-2.44],0.9867226549108304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,19348,99,0.83 [0.57-1.21],0.3432337904442848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,22795,118,1.43 [1.20-1.72],9.134293281619334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,22984,120,2.27 [1.84-2.81],2.5707517663474788e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,22866,117,1.51 [1.21-1.90],0.0002905096777886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,22832,119,1.38 [0.89-2.14],0.1539407327243599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,22907,119,1.64 [1.33-2.03],3.979171078713218e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,22985,119,1.28 [0.87-1.89],0.2173467741533465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,19897,101,0.88 [0.73-1.05],0.149713950433332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,22868,121,1.57 [1.17-2.11],0.0026287149304484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,23103,119,1.48 [0.98-2.24],0.0653801423801743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,19897,101,1.21 [0.87-1.69],0.26504627502755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22754,119,1.52 [0.85-2.72],0.1588086729711345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,19439,99,1.38 [0.59-3.21],0.456204276720364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,22985,119,2.67 [1.79-3.97],1.2822026897767285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,23189,120,2.50 [1.50-4.16],0.0004231783067878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22890,121,1.04 [0.84-1.29],0.7045954143234838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,20025,100,1.69 [0.83-3.43],0.149036027546555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,19260,99,0.90 [0.72-1.13],0.3645752375170107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,22927,121,1.72 [0.98-3.03],0.0576401411252698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,22912,118,2.31 [1.65-3.24],1.3185487014478288e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,22904,119,1.14 [0.80-1.64],0.4612254858979017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,22824,121,1.61 [0.99-2.62],0.0570591343096971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,22478,115,1.06 [0.68-1.63],0.8037136674707026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,19384,97,1.11 [0.97-1.27],0.1435433180264597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,19275,99,0.80 [0.44-1.48],0.480372262800591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,19872,101,0.93 [0.74-1.16],0.507262553135422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,23124,119,2.41 [1.40-4.17],0.0015821561388844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,22220,113,1.01 [0.88-1.17],0.8615143767953336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,23189,120,1.64 [1.04-2.61],0.0352049364711688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22328,115,1.48 [1.07-2.05],0.0185949602720063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19612,99,1.09 [0.66-1.82],0.7320540109059868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22980,119,1.33 [0.93-1.91],0.1167231801826552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20004,98,0.78 [0.47-1.31],0.3467769521883044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19967,101,0.94 [0.75-1.18],0.5932856641018456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,22633,117,2.68 [1.62-4.42],0.000112022872436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,20004,98,1.49 [0.82-2.71],0.1924825823269043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,23024,120,1.05 [0.93-1.18],0.40685962947922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,22912,118,2.67 [1.98-3.59],1.0715847387122776e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,22847,121,2.05 [1.04-4.04],0.0388761025175394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,22985,119,0.93 [0.76-1.15],0.5176962571212995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,19348,99,0.61 [0.34-1.09],0.0960849958038743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",19612,99,1.22 [0.82-1.82],0.3219343243695552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,19439,99,1.53 [0.75-3.15],0.2434151895291852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,19612,99,1.05 [0.45-2.46],0.9065450056399884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,23141,119,1.07 [0.82-1.40],0.6114134399335769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,19439,99,1.98 [1.06-3.70],0.0318607607143295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19440,96,0.90 [0.60-1.36],0.6325205504711562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,19612,99,1.24 [0.95-1.63],0.1180538894629368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,19384,97,1.11 [0.80-1.53],0.543126898215528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,19384,97,1.18 [0.86-1.61],0.3164260450621007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,19900,99,0.91 [0.75-1.10],0.3209507445059466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,19897,101,0.97 [0.74-1.27],0.8233826342903687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,19498,94,0.98 [0.71-1.35],0.8951536918531872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,19980,101,0.86 [0.54-1.38],0.5339737284376592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,19298,99,1.03 [0.64-1.65],0.8986060153477312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,19348,99,0.97 [0.75-1.26],0.8288191630387596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,19930,101,1.67 [1.05-2.67],0.0319810035894414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,22835,117,1.10 [0.92-1.33],0.2834962051409558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,22663,116,1.09 [0.70-1.71],0.6941319811630409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,22912,118,1.06 [0.85-1.32],0.6086137500802321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,22980,119,1.76 [1.25-2.47],0.001088442599708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,22445,115,1.40 [1.05-1.86],0.0200043268893069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19900,99,1.32 [0.91-1.90],0.1396861066492809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22462,118,0.68 [0.42-1.11],0.1221435503177518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19568,96,0.70 [0.50-0.98],0.0397011957396275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22775,117,2.92 [2.05-4.15],2.703375749984314e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22775,117,1.62 [1.33-1.96],9.847381311414736e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22946,120,1.17 [0.85-1.62],0.3300327667255625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23141,119,1.86 [1.27-2.72],0.0014782934928289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22916,119,3.52 [2.20-5.61],1.3931555542076118e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22985,119,2.64 [1.80-3.88],7.181591392586366e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22958,120,1.35 [0.83-2.20],0.2267916645247875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22462,118,0.79 [0.53-1.18],0.2559550730036686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22958,120,2.37 [1.45-3.87],0.0005942065282105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19568,96,0.92 [0.56-1.52],0.7575352779392763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23120,121,2.16 [1.40-3.33],0.0004706265341717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22912,118,3.16 [1.97-5.04],1.601050094188075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22912,118,1.71 [1.33-2.20],3.333809324812977e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23124,119,2.89 [1.64-5.10],0.000253742233915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23103,119,2.17 [1.51-3.14],3.2270646184819345e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22775,117,2.27 [1.84-2.81],4.652150572659757e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23124,119,1.66 [1.20-2.28],0.0019697657562463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22775,117,1.99 [1.42-2.79],5.896126505807988e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,23141,119,0.97 [0.54-1.75],0.9314914915743157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22868,121,0.82 [0.63-1.06],0.1343894890940842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,23141,119,0.47 [0.27-0.81],0.007008637458609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,23024,120,2.84 [1.58-5.12],0.0004847024984177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23148,120,2.89 [1.97-4.24],5.131675920537399e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22775,117,1.30 [0.98-1.73],0.0691386150670357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,20004,99,1.77 [1.07-2.92],0.0259413079901551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,19967,101,1.02 [0.82-1.28],0.838684546935474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,20004,99,0.75 [0.47-1.19],0.2203201018875993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",22478,115,1.14 [0.93-1.40],0.2183543769542026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,19612,99,1.22 [0.72-2.09],0.462699217145178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,22775,117,0.82 [0.55-1.20],0.3006800135934045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,22912,118,1.54 [0.82-2.90],0.1778313773504324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20004,98,1.06 [0.82-1.37],0.6544420107752946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,19900,99,0.89 [0.74-1.08],0.2452463262798379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",19298,99,0.84 [0.54-1.30],0.430065192791537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,19439,99,0.92 [0.71-1.19],0.5028300166897708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,19498,94,1.11 [0.77-1.60],0.5858581617843852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,22367,117,1.14 [0.76-1.69],0.5340875685265951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,19439,99,0.97 [0.76-1.23],0.7928886679287186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,19154,95,0.97 [0.66-1.41],0.8625572491372552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22478,115,1.18 [0.75-1.83],0.4753807754713182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,19440,96,0.74 [0.41-1.32],0.3040170288734211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,19440,96,0.77 [0.46-1.31],0.3368251648074987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,19568,96,0.89 [0.74-1.07],0.2180357614413288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,20004,98,1.15 [0.59-2.23],0.6893745964878548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,19384,97,0.78 [0.45-1.33],0.3552306083994789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,22367,117,0.94 [0.74-1.18],0.5923882765463357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,22770,119,1.60 [1.22-2.09],0.0006666599408889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,19612,99,1.04 [0.82-1.30],0.763594933156142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,22375,115,0.84 [0.52-1.35],0.4767162624786507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,19384,97,1.36 [1.03-1.79],0.0298375217859917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,19298,99,0.88 [0.63-1.24],0.4750708530013058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,23104,118,0.86 [0.62-1.18],0.342293908602435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,19980,101,1.04 [0.63-1.71],0.8875727732574049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,19439,99,1.25 [0.61-2.54],0.5415707752896305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,22462,118,0.79 [0.58-1.07],0.1231060418517268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,22868,121,0.91 [0.72-1.14],0.4004995016163987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19439,99,1.11 [0.65-1.90],0.7052773833895685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19384,97,0.86 [0.55-1.33],0.4941423790112488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19612,99,0.95 [0.75-1.20],0.6519559956087564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,20004,99,1.23 [0.95-1.60],0.1210836413129936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,22916,119,1.67 [1.25-2.22],0.0004397242098331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,20025,100,0.80 [0.55-1.16],0.2345193581917037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,22912,118,0.78 [0.48-1.27],0.3135184374349564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,23120,121,1.13 [0.87-1.46],0.3555777553365731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,22868,121,0.87 [0.72-1.07],0.1833948524091598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,19569,99,0.89 [0.65-1.22],0.4693211128026435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19900,99,0.99 [0.83-1.19],0.9331165916402132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,19298,99,0.89 [0.62-1.29],0.5409179002529991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,19440,96,1.00 [0.75-1.32],0.9868351104207348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,22868,121,1.07 [0.88-1.30],0.5013617798729434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,19897,101,1.01 [0.81-1.26],0.9397055613286104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,19384,97,1.04 [0.72-1.51],0.8226658416255692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,19439,99,1.13 [0.89-1.44],0.3165340648530339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,19980,101,1.12 [0.86-1.45],0.412325268091409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,22927,121,0.92 [0.76-1.11],0.3855484730371891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,22478,115,1.05 [0.79-1.38],0.7483040714584591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,19384,97,0.73 [0.43-1.23],0.235740881313389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,22478,115,1.02 [0.59-1.76],0.9491822364883392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,19384,97,1.03 [0.72-1.48],0.8661634817092109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,19348,99,0.94 [0.74-1.19],0.6159255355051287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,19900,99,1.19 [0.99-1.43],0.0604180946214561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,19439,99,0.92 [0.56-1.52],0.7571158878519453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,22332,115,1.03 [0.83-1.29],0.7899620510001749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,19440,96,0.78 [0.51-1.21],0.2648145102817143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,19384,97,1.07 [0.80-1.42],0.6519466267637144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,19813,97,0.81 [0.39-1.70],0.5792787589192638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,19348,99,0.98 [0.50-1.92],0.9469113509760618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,20004,99,0.93 [0.73-1.17],0.5249646330953534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,19612,99,0.88 [0.66-1.18],0.3902026347852593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,22775,117,0.98 [0.81-1.19],0.8662446160594817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,19699,99,0.87 [0.54-1.39],0.5573992047988106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,22985,119,2.21 [1.26-3.88],0.0056712525368452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,23124,119,1.10 [0.87-1.40],0.4319119773338848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,19967,101,0.85 [0.58-1.25],0.4111589197141391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,19308,99,0.91 [0.72-1.16],0.460287009337833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22912,118,1.00 [0.70-1.44],0.9866438968228228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,22774,121,1.11 [0.87-1.41],0.4024230905864333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,22927,121,2.16 [1.21-3.83],0.0088910236563101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19439,99,1.71 [1.21-2.41],0.0023553160827252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,22835,117,1.38 [0.86-2.20],0.1775912852096397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,19897,101,0.95 [0.47-1.92],0.8856645765805189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20004,98,1.05 [0.76-1.44],0.789083565814199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19439,99,0.97 [0.68-1.38],0.8688237735688952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,19384,97,1.30 [0.93-1.82],0.120338165922254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,19568,96,0.87 [0.65-1.18],0.3820980996422483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19900,99,0.93 [0.81-1.07],0.3145840391362934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,19384,97,0.92 [0.73-1.15],0.4528756653311359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,19384,97,1.27 [0.78-2.07],0.3308216608297665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,22775,117,2.32 [1.57-3.44],2.5655888304031035e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,23121,119,0.60 [0.46-0.79],0.0001985310199145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,19439,99,1.16 [0.55-2.46],0.6976279788736655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,19298,99,0.85 [0.59-1.22],0.379058744051569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,19897,101,1.03 [0.56-1.90],0.9204555582002142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,20004,98,1.34 [1.11-1.62],0.002074065632821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,19348,99,1.04 [0.71-1.54],0.8311503954856589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,19576,99,0.91 [0.62-1.34],0.6261469709083449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,19568,96,0.83 [0.62-1.12],0.2241786804580391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,19440,96,1.06 [0.82-1.38],0.6537477953288484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,22835,117,1.03 [0.86-1.24],0.7328938616991216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19897,101,0.93 [0.71-1.22],0.6114155412705613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19967,101,1.14 [0.73-1.78],0.5635604554326198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19384,97,0.75 [0.57-1.00],0.0481153841606014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22478,115,1.00 [0.84-1.20],0.9996147999642512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,22367,117,1.12 [0.83-1.51],0.4687119880488488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,22478,115,1.55 [1.25-1.92],5.657297365552891e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,19439,99,1.00 [0.80-1.25],0.9971516463637362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22868,121,0.91 [0.74-1.12],0.3513364158622949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,22527,118,1.09 [0.60-1.99],0.7709070508155698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,20025,100,0.88 [0.67-1.16],0.357849659628681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22835,117,0.85 [0.37-1.96],0.704075913914977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,19348,99,0.91 [0.74-1.11],0.3469993489844671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,22942,119,2.10 [1.21-3.65],0.0085732689670431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,23124,119,1.62 [0.95-2.76],0.0771342622740941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,19298,99,1.00 [0.80-1.26],0.9741672452971076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,23065,119,1.35 [1.04-1.75],0.0232485248246986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,19439,99,1.32 [0.65-2.67],0.4479654538027342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,22985,119,0.81 [0.60-1.09],0.1608797962352331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,23096,119,0.81 [0.50-1.32],0.3963446235619778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,19980,101,1.09 [0.59-2.01],0.79342447067802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,22478,115,1.04 [0.90-1.21],0.5928598685076814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,19498,94,0.99 [0.43-2.25],0.9782452651760218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,20004,98,2.43 [1.51-3.90],0.0002613009828339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,22835,117,1.22 [0.94-1.59],0.1321904937061465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,20025,100,1.21 [0.92-1.59],0.1834841185789378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,22835,117,1.55 [1.06-2.26],0.0247988068092273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19612,99,0.86 [0.62-1.17],0.3364413470593498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,22835,117,0.95 [0.77-1.18],0.6703572270353751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,19897,101,0.90 [0.73-1.10],0.3011717843064765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22835,117,0.91 [0.72-1.14],0.3939118985510822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,19897,101,1.20 [0.76-1.90],0.4434016237496231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19384,97,1.46 [0.88-2.44],0.143893761293328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,19897,101,2.30 [1.79-2.97],1.1688053611096715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,22882,116,2.08 [1.43-3.03],0.0001256705813057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22897,121,0.98 [0.76-1.27],0.8940023919721821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,19967,101,2.04 [1.35-3.10],0.0007833256968006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,22375,115,1.13 [0.80-1.61],0.4786495949016778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,19612,99,1.14 [0.74-1.77],0.5529033270700163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22478,115,1.21 [0.93-1.56],0.1547016734425673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23124,119,0.90 [0.72-1.14],0.3800433546709754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22367,117,1.04 [0.61-1.77],0.8803609486213888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19568,96,0.94 [0.67-1.33],0.7331521177777347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,23084,121,2.22 [1.57-3.15],6.176489899002826e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,19298,99,1.11 [0.91-1.35],0.3195160895075475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,22691,117,1.86 [1.23-2.81],0.0033605295140268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,19980,101,0.81 [0.50-1.32],0.401876665655507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,23189,120,1.24 [0.99-1.55],0.0577126006687722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22912,118,1.34 [0.86-2.08],0.1915191041834916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,22462,118,0.91 [0.71-1.17],0.4539041944928015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,22478,115,0.96 [0.80-1.16],0.679580126971931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,22375,115,0.91 [0.75-1.11],0.3633673297058791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,19967,101,0.90 [0.69-1.18],0.4581521928516355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,19439,99,0.80 [0.55-1.15],0.2234310465792245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,19897,101,0.94 [0.54-1.61],0.815218630166578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,19498,101,1.26 [0.95-1.67],0.1053476362001773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,23085,120,1.47 [1.16-1.86],0.0012664117348397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,21736,112,2.81 [2.08-3.79],1.8299966592571832e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22705,117,0.34 [0.23-0.50],5.55050960928672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22958,120,0.94 [0.59-1.49],0.7871367090758264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,23120,121,1.05 [0.66-1.68],0.8206569534756476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,22462,118,1.47 [0.91-2.36],0.113490638016285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22775,117,1.00 [0.73-1.36],0.9755710627881512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,23120,121,1.15 [0.88-1.51],0.3127624231853433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,23075,119,1.45 [0.87-2.40],0.1517017442816907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,19439,99,0.91 [0.64-1.29],0.5884363667256987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,22985,119,1.08 [0.90-1.30],0.4163344008223681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,22375,115,1.19 [0.77-1.82],0.4318144946965787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,19967,101,3.33 [1.87-5.92],4.1875033245401056e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19900,99,1.00 [0.88-1.15],0.9558338184501282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,22835,117,0.97 [0.84-1.13],0.7007737485946197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,19897,101,1.04 [0.58-1.87],0.901861669254426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,19384,97,1.00 [0.73-1.37],0.9930769112718516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,22462,118,0.94 [0.77-1.15],0.5401645594887188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,19568,96,0.87 [0.66-1.16],0.346886360159477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,19439,99,0.69 [0.33-1.44],0.3227579120557168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,19439,99,0.90 [0.53-1.54],0.7041303166876928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,22367,117,1.03 [0.81-1.31],0.8081242454347943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,22478,115,1.72 [1.30-2.28],0.0001530607328512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19384,97,0.96 [0.70-1.32],0.7940318280053363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,19900,99,0.87 [0.70-1.09],0.2198030298370613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,19967,101,1.50 [1.01-2.24],0.0460536266020974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,19439,99,0.79 [0.42-1.48],0.4601757479800019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,19612,99,1.25 [0.97-1.61],0.0821534553831667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,19897,101,1.00 [0.79-1.27],0.994386843455734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,19900,99,0.97 [0.73-1.28],0.8193699603725793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19897,101,0.89 [0.62-1.29],0.5444065960822203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,19498,94,1.06 [0.98-1.15],0.1599121669937664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,19298,99,1.14 [0.71-1.83],0.5838653522161432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,19348,99,0.98 [0.80-1.21],0.8702559213715279
